| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | HIVEP2 IRX5 SALL3 PDX1 PGR EBF2 HOXB1 NKX2-8 NFATC2 SKOR2 BHLHE22 VAX2 TET3 FOXO1 ZNF704 MEF2B HDAC5 KLF6 EBF3 CC2D1B HES3 ZNF581 TEAD3 RUNX1 RUNX3 CREB3L1 ZFHX4 ELK3 ZNF583 NEUROG3 CUX1 SP7 ZNF646 | 3.78e-07 | 1244 | 203 | 33 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | HIVEP2 IRX5 SALL3 PDX1 PGR EBF2 HOXB1 NKX2-8 NFATC2 SKOR2 BHLHE22 VAX2 TET3 FOXO1 ZNF704 MEF2B HDAC5 KLF6 EBF3 CC2D1B HES3 ZNF581 TEAD3 RUNX1 RUNX3 CREB3L1 ZFHX4 ELK3 ZNF583 NEUROG3 CUX1 SP7 ZNF646 | 6.13e-07 | 1271 | 203 | 33 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | HIVEP2 IRX5 SALL3 PDX1 ETV3 PGR EBF2 HOXB1 NKX2-8 NFATC2 SKOR2 BHLHE22 VAX2 TET3 FOXO1 ZNF704 MEF2B HDAC5 KLF6 EBF3 CC2D1B HES3 ZNF581 TEAD3 RUNX1 RUNX3 CREB3L1 ZFHX4 ELK3 ZNF583 NEUROG3 CUX1 SP7 ZNF646 | 4.51e-06 | 1459 | 203 | 34 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | HIVEP2 IRX5 SALL3 PDX1 ETV3 PGR EBF2 HOXB1 NKX2-8 NFATC2 SKOR2 BHLHE22 VAX2 MYRF FOXO1 MEF2B HDAC5 KLF6 EBF3 JPH2 CC2D1B HES3 TEAD3 RUNX1 RUNX3 CREB3L1 ZFHX4 ELK3 ZNF583 NEUROG3 CUX1 SP7 ZNF646 | 6.00e-06 | 1412 | 203 | 33 | GO:0000981 |
| GeneOntologyMolecularFunction | chromatin binding | NCOA6 PDX1 EBF2 NFATC2 SKOR2 BHLHE22 KMT2A VAX2 FOXO1 TICRR HDAC5 EP400 RUNX1 CREB3L1 EPOP TLE4 EXO1 AUTS2 RERE L3MBTL3 NEUROG3 CUX1 | 6.77e-06 | 739 | 203 | 22 | GO:0003682 |
| GeneOntologyMolecularFunction | choline-phosphate cytidylyltransferase activity | 1.03e-04 | 2 | 203 | 2 | GO:0004105 | |
| GeneOntologyMolecularFunction | SH3 domain binding | 1.09e-04 | 143 | 203 | 8 | GO:0017124 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 1.23e-04 | 229 | 203 | 10 | GO:0003714 | |
| GeneOntologyMolecularFunction | actin binding | TPRN ANLN COBL MICAL3 EVL WIPF1 SYNE1 TRIOBP GAS2L1 TLNRD1 LDB3 FHOD1 SIPA1L1 TNS1 | 4.09e-04 | 479 | 203 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | ETV3 NFATC2 VAX2 FOXO1 HDAC5 JPH2 CC2D1B HES3 CREB3L1 ELK3 NEUROG3 | 4.53e-04 | 320 | 203 | 11 | GO:0001227 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | ETV3 NFATC2 VAX2 FOXO1 HDAC5 JPH2 CC2D1B HES3 CREB3L1 ELK3 NEUROG3 | 5.29e-04 | 326 | 203 | 11 | GO:0001217 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | HIVEP2 PGR EBF2 HOXB1 NKX2-8 NFATC2 FOXO1 MEF2B KLF6 EBF3 RUNX1 CREB3L1 ELK3 NEUROG3 SP7 | 6.33e-04 | 560 | 203 | 15 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | HIVEP2 PGR EBF2 HOXB1 NKX2-8 NFATC2 FOXO1 MEF2B KLF6 EBF3 RUNX1 CREB3L1 ELK3 NEUROG3 SP7 | 7.06e-04 | 566 | 203 | 15 | GO:0001216 |
| GeneOntologyBiologicalProcess | neuron development | IRX5 SALL3 RAPH1 UBE4B TPRN DAB1 CSMD3 TAOK2 STRN NKX2-8 PTPRG SKOR2 BHLHE22 COBL VAX2 FLRT2 TRIM46 CUL4B EVL ROBO4 SLC4A7 SZT2 SYNE1 CECR2 RTN4 APC TRIOBP SLITRK3 RUNX1 RUNX3 MICALL1 TENM4 SIPA1L1 AUTS2 ROBO2 RERE CTNND2 AGRN TNXB NEUROG3 CUX1 INPP5J OTOG EPHA8 | 1.10e-11 | 1463 | 200 | 44 | GO:0048666 |
| GeneOntologyBiologicalProcess | neuron projection development | RAPH1 UBE4B TPRN DAB1 CSMD3 TAOK2 STRN NKX2-8 PTPRG SKOR2 BHLHE22 COBL VAX2 FLRT2 TRIM46 CUL4B EVL ROBO4 SZT2 SYNE1 CECR2 RTN4 APC TRIOBP SLITRK3 RUNX3 MICALL1 SIPA1L1 AUTS2 ROBO2 RERE CTNND2 AGRN TNXB NEUROG3 CUX1 INPP5J OTOG EPHA8 | 1.59e-10 | 1285 | 200 | 39 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | RAPH1 TPRN DAB1 TAOK2 NKX2-8 SKOR2 BHLHE22 COBL VAX2 FLRT2 TRIM46 EVL ROBO4 SZT2 SYNE1 RTN4 APC TRIOBP SLITRK3 RUNX3 SIPA1L1 AUTS2 ROBO2 RERE CTNND2 AGRN NEUROG3 CUX1 EPHA8 | 2.00e-10 | 748 | 200 | 29 | GO:0048667 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | RAPH1 DAB1 TAOK2 NKX2-8 SKOR2 BHLHE22 COBL VAX2 FLRT2 TRIM46 EVL ROBO4 SZT2 SYNE1 RTN4 APC SLITRK3 RUNX3 SIPA1L1 AUTS2 ROBO2 RERE CTNND2 AGRN NEUROG3 CUX1 EPHA8 | 1.81e-08 | 802 | 200 | 27 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | RAPH1 DAB1 TAOK2 NKX2-8 SKOR2 BHLHE22 COBL VAX2 FLRT2 TRIM46 EVL ROBO4 SZT2 SYNE1 RTN4 APC SLITRK3 RUNX3 SIPA1L1 AUTS2 ROBO2 RERE CTNND2 AGRN NEUROG3 CUX1 EPHA8 | 2.79e-08 | 819 | 200 | 27 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | RAPH1 DAB1 TAOK2 NKX2-8 SKOR2 BHLHE22 COBL VAX2 FLRT2 TRIM46 EVL ROBO4 SZT2 SYNE1 RTN4 APC SLITRK3 RUNX3 SIPA1L1 AUTS2 ROBO2 RERE CTNND2 AGRN NEUROG3 CUX1 EPHA8 | 3.32e-08 | 826 | 200 | 27 | GO:0048858 |
| GeneOntologyBiologicalProcess | axonogenesis | RAPH1 DAB1 TAOK2 NKX2-8 BHLHE22 COBL VAX2 FLRT2 TRIM46 EVL ROBO4 SZT2 RTN4 APC SLITRK3 RUNX3 SIPA1L1 AUTS2 ROBO2 AGRN EPHA8 | 1.60e-07 | 566 | 200 | 21 | GO:0007409 |
| GeneOntologyBiologicalProcess | axon development | RAPH1 DAB1 TAOK2 NKX2-8 BHLHE22 COBL VAX2 FLRT2 TRIM46 EVL ROBO4 SZT2 RTN4 APC SLITRK3 RUNX3 SIPA1L1 AUTS2 ROBO2 AGRN NEUROG3 EPHA8 | 3.11e-07 | 642 | 200 | 22 | GO:0061564 |
| GeneOntologyBiologicalProcess | cell morphogenesis | RAPH1 TPRN DAB1 TAOK2 NKX2-8 SKOR2 BHLHE22 COBL VAX2 FLRT2 DNMBP TRIM46 EVL ROBO4 SZT2 SYNE1 RTN4 APC TRIOBP SLITRK3 RUNX3 SIPA1L1 AUTS2 ROBO2 RERE CTNND2 AGRN NEUROG3 CUX1 EPHA8 | 1.58e-06 | 1194 | 200 | 30 | GO:0000902 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | NCOA6 HIVEP2 PDX1 POGZ BCL3 PGR EBF2 HOXB1 KMT2C NKX2-8 NFATC2 BHLHE22 KMT2A MED26 TET3 FOXO1 MEF2B HDAC5 KLF6 EBF3 HES3 TEAD3 RUNX1 CREB3L1 FHOD1 AUTS2 ELK3 AGRN NEUROG3 SP7 ZNF646 | 1.17e-05 | 1390 | 200 | 31 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | KDM5B TOB2 KDM5C PDX1 ETV3 BCL3 NFATC2 SKOR2 BHLHE22 VAX2 FOXO1 HDAC5 JPH2 CC2D1B HES3 RUNX1 RUNX3 MIER1 CREB3L1 SETD5 ATF7IP TLE2 TLE4 ELK3 VGLL4 RERE L3MBTL3 NEUROG3 CUX1 | 8.65e-05 | 1399 | 200 | 29 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | KDM5B TOB2 KDM5C PDX1 ETV3 BCL3 NFATC2 SKOR2 BHLHE22 VAX2 FOXO1 HDAC5 JPH2 CC2D1B HES3 RUNX1 RUNX3 MIER1 CREB3L1 SETD5 ATF7IP TLE2 TLE4 ELK3 VGLL4 RERE L3MBTL3 NEUROG3 CUX1 | 1.03e-04 | 1413 | 200 | 29 | GO:1902679 |
| GeneOntologyBiologicalProcess | dendrite development | DAB1 CSMD3 TAOK2 STRN SKOR2 COBL SYNE1 SIPA1L1 RERE CTNND2 NEUROG3 CUX1 | 1.11e-04 | 335 | 200 | 12 | GO:0016358 |
| GeneOntologyCellularComponent | actomyosin | 2.15e-06 | 117 | 203 | 9 | GO:0042641 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 9.87e-06 | 107 | 203 | 8 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 9.87e-06 | 107 | 203 | 8 | GO:0001725 | |
| GeneOntologyCellularComponent | actin cytoskeleton | PPP1R12B DAPK1 ZYX TAOK2 ANLN COBL BIN2 EVL CDC42BPA WIPF1 TRIOBP GAS2L1 TLNRD1 LDB3 FHOD1 SIPA1L1 AUTS2 SEPTIN12 | 1.41e-05 | 576 | 203 | 18 | GO:0015629 |
| GeneOntologyCellularComponent | chromatin | KDM5B IRX5 KDM5C PDX1 ETV3 POGZ PGR EBF2 HOXB1 NKX2-8 NFATC2 UBR5 BHLHE22 VAX2 FOXO1 MEF2B HDAC5 EP400 KLF6 EBF3 CECR2 HES3 TEAD3 RUNX1 RUNX3 CREB3L1 ZFHX4 SETD5 ELK3 NEUROG3 CUX1 SP7 | 1.62e-05 | 1480 | 203 | 32 | GO:0000785 |
| GeneOntologyCellularComponent | actin filament bundle | 2.02e-05 | 118 | 203 | 8 | GO:0032432 | |
| GeneOntologyCellularComponent | axonal growth cone | 7.32e-05 | 45 | 203 | 5 | GO:0044295 | |
| GeneOntologyCellularComponent | transcription regulator complex | NCOA6 HIVEP2 ETV3 NFATC2 SKOR2 MED26 MEF2B HDAC5 TEAD3 RUNX1 RUNX3 MIER1 ATF7IP TLE2 TLE4 DCP1A | 2.47e-04 | 596 | 203 | 16 | GO:0005667 |
| GeneOntologyCellularComponent | core-binding factor complex | 2.80e-04 | 3 | 203 | 2 | GO:0016513 | |
| MousePheno | abnormal axon guidance | 1.74e-05 | 45 | 172 | 6 | MP:0002961 | |
| Domain | fn3 | IL12RB2 SPEG FNDC1 PTPRG FLRT2 TRIM46 ROBO4 ROBO2 TNXB EPHA8 | 7.30e-06 | 162 | 193 | 10 | PF00041 |
| Domain | FN3 | IL12RB2 SPEG FNDC1 PTPRG FLRT2 TRIM46 ROBO4 ATF7IP ROBO2 TNXB EPHA8 | 7.32e-06 | 199 | 193 | 11 | PS50853 |
| Domain | FN3_dom | IL12RB2 SPEG FNDC1 PTPRG FLRT2 TRIM46 ROBO4 ATF7IP ROBO2 TNXB EPHA8 | 1.16e-05 | 209 | 193 | 11 | IPR003961 |
| Domain | FN3 | IL12RB2 SPEG FNDC1 PTPRG FLRT2 TRIM46 ROBO4 ROBO2 TNXB EPHA8 | 2.33e-05 | 185 | 193 | 10 | SM00060 |
| Domain | Homeodomain-like | IRX5 TIGD1 PDX1 POGZ HOXB1 NKX2-8 VAX2 EP400 TEAD3 MIER1 ZFHX4 RERE CUX1 | 4.36e-05 | 332 | 193 | 13 | IPR009057 |
| Domain | Runt | 3.17e-04 | 3 | 193 | 2 | PF00853 | |
| Domain | RUNT | 3.17e-04 | 3 | 193 | 2 | PS51062 | |
| Domain | TF_Runt-rel_RUNX | 3.17e-04 | 3 | 193 | 2 | IPR016554 | |
| Domain | RunxI | 3.17e-04 | 3 | 193 | 2 | PF08504 | |
| Domain | Runt_dom | 3.17e-04 | 3 | 193 | 2 | IPR013524 | |
| Domain | RunxI_C_dom | 3.17e-04 | 3 | 193 | 2 | IPR013711 | |
| Domain | Runx_central_dom | 3.17e-04 | 3 | 193 | 2 | IPR027384 | |
| Domain | muHD | 3.17e-04 | 3 | 193 | 2 | PF10291 | |
| Domain | - | 3.17e-04 | 3 | 193 | 2 | 4.10.770.10 | |
| Domain | Muniscin_C | 3.17e-04 | 3 | 193 | 2 | IPR018808 | |
| Domain | AML1_Runt | 3.17e-04 | 3 | 193 | 2 | IPR000040 | |
| Domain | - | IL12RB2 SPEG CEACAM3 EBF2 FNDC1 PTPRG NFATC2 FLRT2 TRIM46 ROBO4 EBF3 NRG2 ATF7IP ROBO2 LY9 TNXB EPHA8 | 5.40e-04 | 663 | 193 | 17 | 2.60.40.10 |
| Domain | AT_hook | 5.51e-04 | 16 | 193 | 3 | PF02178 | |
| Domain | Lys_sp_deMease-like_dom | 6.29e-04 | 4 | 193 | 2 | IPR013637 | |
| Domain | ROC_dom | 6.29e-04 | 4 | 193 | 2 | IPR020859 | |
| Domain | ROC | 6.29e-04 | 4 | 193 | 2 | PS51424 | |
| Domain | COE | 6.29e-04 | 4 | 193 | 2 | PS01345 | |
| Domain | Transcription_factor_COE | 6.29e-04 | 4 | 193 | 2 | IPR003523 | |
| Domain | PLU-1 | 6.29e-04 | 4 | 193 | 2 | PF08429 | |
| Domain | COE_HLH | 6.29e-04 | 4 | 193 | 2 | IPR032201 | |
| Domain | COE_DBD | 6.29e-04 | 4 | 193 | 2 | IPR032200 | |
| Domain | Transcription_factor_COE_CS | 6.29e-04 | 4 | 193 | 2 | IPR018350 | |
| Domain | COE1_HLH | 6.29e-04 | 4 | 193 | 2 | PF16423 | |
| Domain | COE1_DBD | 6.29e-04 | 4 | 193 | 2 | PF16422 | |
| Domain | - | 7.86e-04 | 70 | 193 | 5 | 2.10.110.10 | |
| Domain | - | RAPH1 DAB1 SPRED3 ASAP2 ANLN RABGAP1L EVL CDC42BPA ARHGAP10 TRIOBP TNS1 DCP1A | 7.88e-04 | 391 | 193 | 12 | 2.30.29.30 |
| Domain | LIM | 8.39e-04 | 71 | 193 | 5 | SM00132 | |
| Domain | Znf_LIM | 8.39e-04 | 71 | 193 | 5 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 8.39e-04 | 71 | 193 | 5 | PS00478 | |
| Domain | LIM_DOMAIN_2 | 8.39e-04 | 71 | 193 | 5 | PS50023 | |
| Domain | BAR | 9.32e-04 | 19 | 193 | 3 | PS51021 | |
| Domain | FYrich_C | 1.04e-03 | 5 | 193 | 2 | IPR003889 | |
| Domain | FYrich_N | 1.04e-03 | 5 | 193 | 2 | IPR003888 | |
| Domain | FYRC | 1.04e-03 | 5 | 193 | 2 | SM00542 | |
| Domain | FYRN | 1.04e-03 | 5 | 193 | 2 | SM00541 | |
| Domain | Groucho_enhance | 1.04e-03 | 5 | 193 | 2 | IPR009146 | |
| Domain | TLE_N | 1.04e-03 | 5 | 193 | 2 | PF03920 | |
| Domain | Groucho/TLE_N | 1.04e-03 | 5 | 193 | 2 | IPR005617 | |
| Domain | zf-C5HC2 | 1.04e-03 | 5 | 193 | 2 | PF02928 | |
| Domain | Znf_C5HC2 | 1.04e-03 | 5 | 193 | 2 | IPR004198 | |
| Domain | FYRN | 1.04e-03 | 5 | 193 | 2 | PF05964 | |
| Domain | FYRC | 1.04e-03 | 5 | 193 | 2 | PF05965 | |
| Domain | FYRC | 1.04e-03 | 5 | 193 | 2 | PS51543 | |
| Domain | FYRN | 1.04e-03 | 5 | 193 | 2 | PS51542 | |
| Domain | Ig-like_fold | IL12RB2 SPEG CEACAM3 EBF2 FNDC1 PTPRG NFATC2 FLRT2 TRIM46 ROBO4 EBF3 NRG2 ATF7IP ROBO2 LY9 TNXB EPHA8 | 1.08e-03 | 706 | 193 | 17 | IPR013783 |
| Domain | p53/RUNT-type_TF_DNA-bd | 1.55e-03 | 6 | 193 | 2 | IPR012346 | |
| Domain | - | 1.55e-03 | 6 | 193 | 2 | 2.60.40.720 | |
| Domain | PH_dom-like | RAPH1 DAB1 SPRED3 ASAP2 ANLN RABGAP1L EVL CDC42BPA ARHGAP10 TRIOBP TNS1 DCP1A | 1.64e-03 | 426 | 193 | 12 | IPR011993 |
| Domain | DUF3585 | 2.16e-03 | 7 | 193 | 2 | IPR022735 | |
| Domain | DUF3585 | 2.16e-03 | 7 | 193 | 2 | PF12130 | |
| Domain | CTP_transf_like | 2.16e-03 | 7 | 193 | 2 | PF01467 | |
| Domain | Cyt_trans-like | 2.16e-03 | 7 | 193 | 2 | IPR004821 | |
| Domain | p53-like_TF_DNA-bd | 2.18e-03 | 53 | 193 | 4 | IPR008967 | |
| Pubmed | DOCK4 TOB2 UBE4B SPEG DGKB POGZ CSMD3 DNAJC6 KLHL29 UBR5 RABGAP1L SEL1L3 COBL MICAL3 TET3 HDAC5 EP400 SYNE1 TENM4 SETD5 BTBD7 TLE4 NISCH SIPA1L1 PPIP5K1 RERE SRRM2 CEP170B | 2.13e-21 | 407 | 209 | 28 | 12693553 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SRRM1 NCOA6 RAPH1 UBE4B KDM5C POGZ FAM53C ZYX ANLN KMT2A MICAL3 DNMBP CUL4B EVL SRSF6 EP400 BUD13 RUNX1 MIER1 MICALL1 LIG1 USP10 TLE4 FHOD1 SIPA1L1 EXO1 TJAP1 ELK3 RERE SRRM2 DCP1A | 7.68e-17 | 774 | 209 | 31 | 15302935 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NCOA6 HIVEP2 TBKBP1 UBE4B SPEG TAOK2 KMT2C COBL MICAL3 DTX2 DNMBP MYRF KIAA0930 CDC42BPA EP400 SZT2 RTTN LRRK1 DENND1A MICALL1 PIKFYVE GAS2L1 TLNRD1 GAREM2 EPOP TRAPPC12 SETD5 BTBD7 CCDC34 NISCH ZFYVE26 AGRN CEP170B | 3.22e-14 | 1105 | 209 | 33 | 35748872 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DOCK4 TNK1 SRRM1 KDM5B NCOA6 HIVEP2 RAPH1 FAM53C ZYX BORCS5 ANLN RABGAP1L KMT2A COBL DNMBP FOXO1 KIAA0930 SLC4A7 CDC42BPA APC DENND1A MICALL1 SIPA1L1 EXO1 SRRM2 SH3RF3 CEP170B DCP1A OTOG | 6.88e-14 | 861 | 209 | 29 | 36931259 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | HIVEP2 IRX5 PDX1 ETV3 PGR HOXB1 NKX2-8 NFATC2 SKOR2 BHLHE22 KMT2A VAX2 MYRF FOXO1 KLF6 EBF3 HES3 TEAD3 RUNX1 RUNX3 MIER1 CREB3L1 ZFHX4 ELK3 RERE NEUROG3 SP7 | 9.49e-12 | 908 | 209 | 27 | 19274049 |
| Pubmed | NCOA6 KDM5C POGZ TAOK2 KMT2C DNMBP USP36 CDC42BPA EP400 SZT2 CECR2 RTN4 TRIOBP LRRK1 MIER1 MICALL1 USP10 AUTS2 ROBO2 L3MBTL3 ZNF646 | 1.17e-11 | 529 | 209 | 21 | 14621295 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | HIVEP2 TBKBP1 UBE4B DAB1 KLHL29 KMT2C ASAP2 PTPRG FBXO42 SEL1L3 COBL MICAL3 TET3 ZNF704 EVL CDC42BPA ARHGAP10 TRIOBP SLITRK3 DENND1A USP10 BRI3BP SETD5 AUTS2 TJAP1 ELK3 VGLL4 RERE SH3RF3 CEP170B CUX1 | 1.73e-09 | 1489 | 209 | 31 | 28611215 |
| Pubmed | DAPK1 DNAJC6 CCDC177 ITIH4 TAOK2 STRN UBR5 TRIM46 SGIP1 PRR36 EBF3 SYNE1 APC TRIOBP USP10 ATF7IP NISCH SIPA1L1 TJAP1 CTNND2 TNS1 AGRN CEP170B CUX1 | 4.79e-09 | 963 | 209 | 24 | 28671696 | |
| Pubmed | HIVEP2 POGZ FAM53C ZYX KMT2C ASAP2 POM121 COBL CDC42BPA WIPF1 SYNE1 APC CBLB ATF7IP FHOD1 TNS1 CUX1 | 7.63e-09 | 486 | 209 | 17 | 20936779 | |
| Pubmed | Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS. | 2.01e-08 | 108 | 209 | 9 | 19531213 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | DOCK4 GRIPAP1 TBKBP1 KDM5C TPRN SGO1 STRN UBR5 FBXO42 DNMBP FOXO1 HDAC5 EP400 POLDIP3 APC PIKFYVE ATF7IP CEP170B | 2.12e-08 | 588 | 209 | 18 | 38580884 |
| Pubmed | Characterization of cDNA clones in size-fractionated cDNA libraries from human brain. | 4.62e-08 | 56 | 209 | 7 | 9455484 | |
| Pubmed | KDM5B HIVEP2 ZNF185 POGZ ZYX PGR KMT2C NFATC2 KMT2A FOXO1 KLF6 EBF3 RTN4 PIKFYVE LDB3 ELK3 CUX1 DCP1A SP7 | 6.89e-08 | 709 | 209 | 19 | 22988430 | |
| Pubmed | SRRM1 IL12RB2 KDM5C TPRN POGZ FAM53C PSMG3-AS1 ITIH4 GJD4 UBR5 VAX2 CUL4B USP36 EP400 ARHGAP10 CECR2 BUD13 ZFHX4 SETD5 SIPA1L1 RERE SRRM2 CEP170B ZNF646 | 7.73e-08 | 1116 | 209 | 24 | 31753913 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | IRX5 PDX1 ETV3 HOXB1 NKX2-8 NFATC2 SKOR2 BHLHE22 VAX2 ZNF704 MEF2B KLF6 RUNX3 CREB3L1 ELK3 CUX1 | 2.27e-07 | 544 | 209 | 16 | 28473536 |
| Pubmed | KDM5B RAPH1 POGZ UBR5 CSTPP1 HDAC5 APC ZFHX4 ATF7IP TLE4 RERE L3MBTL3 CUX1 DCP1A | 2.82e-07 | 418 | 209 | 14 | 34709266 | |
| Pubmed | 7.09e-07 | 52 | 209 | 6 | 9455477 | ||
| Pubmed | 8.68e-07 | 13 | 209 | 4 | 24619213 | ||
| Pubmed | NCOA6 KMT2C UBR5 CUL4B HDAC5 SYNE1 TRIOBP TENM4 SIPA1L1 AUTS2 | 1.21e-06 | 225 | 209 | 10 | 12168954 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | NCOA6 HIVEP2 TBKBP1 POGZ KMT2C KMT2A HDAC5 EP400 ZFHX4 TLE4 AUTS2 RERE | 1.65e-06 | 351 | 209 | 12 | 38297188 |
| Pubmed | Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. | 2.12e-06 | 5 | 209 | 3 | 17377532 | |
| Pubmed | Control of neuronal morphology by the atypical cadherin Fat3. | 2.18e-06 | 16 | 209 | 4 | 21903076 | |
| Pubmed | 3.22e-06 | 251 | 209 | 10 | 29031500 | ||
| Pubmed | TBKBP1 STRN UBR5 KIAA0930 HDAC5 APC TEAD3 DENND1A USP10 SIPA1L1 EXO1 SH3RF3 CEP170B | 3.50e-06 | 446 | 209 | 13 | 24255178 | |
| Pubmed | 3.63e-06 | 18 | 209 | 4 | 33658226 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | DOCK4 GRIPAP1 TBKBP1 RAPH1 ZNF185 STRN BORCS5 UBR5 COBL MICAL3 DNMBP CUL4B APC FCHO2 MICALL1 SIPA1L1 AGRN CEP170B | 4.63e-06 | 853 | 209 | 18 | 28718761 |
| Pubmed | 4.86e-06 | 263 | 209 | 10 | 20932939 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | KDM5C POGZ NFATC2 UBR5 FBXO42 FOXO1 MEF2B SLC4A7 HDAC5 EP400 EBF3 ARHGAP10 ZFHX4 TLE4 NISCH L3MBTL3 CUX1 DCP1A | 4.93e-06 | 857 | 209 | 18 | 25609649 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | GRIPAP1 TBKBP1 FAM53C ZYX STRN ASAP2 POM121 PTPRG RABGAP1L CUL4B KIAA0930 HDAC5 SRSF6 EBF3 ARHGAP10 DENND1A RNF126 MICALL1 SETD5 NISCH SIPA1L1 SH3RF3 DCP1A | 5.31e-06 | 1321 | 209 | 23 | 27173435 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | POGZ KMT2C ANLN EP400 KLF6 CECR2 APC MSH4 ZFHX4 ATF7IP AUTS2 CUX1 | 5.95e-06 | 398 | 209 | 12 | 35016035 |
| Pubmed | NCOA6 ETV3 POGZ KMT2C KMT2A CDC42BPA HDAC5 EP400 KLF6 POLDIP3 TEAD3 MIER1 ZFHX4 ATF7IP TLE4 AUTS2 ELK3 VGLL4 RERE SRRM2 L3MBTL3 CUX1 DCP1A SP7 | 6.00e-06 | 1429 | 209 | 24 | 35140242 | |
| Pubmed | PPP1R12B ZNF185 DGKB DAPK1 DNAJC6 CCDC177 STRN KMT2A MICAL3 TRIM46 EVL SGIP1 PRR36 SYNE1 RTN4 APC GAS2L1 USP10 TENM4 NISCH SIPA1L1 CTNND2 TNS1 CEP170B | 6.14e-06 | 1431 | 209 | 24 | 37142655 | |
| Pubmed | NCOA6 RAPH1 STRN ANLN USP36 EP400 POLDIP3 FCHO2 LIG1 FHOD1 SRRM2 CUX1 DCP1A | 6.45e-06 | 472 | 209 | 13 | 38943005 | |
| Pubmed | Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition. | 7.00e-06 | 21 | 209 | 4 | 27626377 | |
| Pubmed | KDM5B SALL3 KDM5C ETV3 POGZ BCL3 ZYX FOXO1 ZNF704 KLF6 EBF3 RUNX3 ZBTB44 BTBD7 NEUROG3 CUX1 ZNF646 | 8.92e-06 | 808 | 209 | 17 | 20412781 | |
| Pubmed | SRRM1 DNAJC6 MICAL3 SGIP1 RTN4 APC NRG2 SIPA1L1 CTNND2 SRRM2 CEP170B | 9.17e-06 | 347 | 209 | 11 | 17114649 | |
| Pubmed | GRIPAP1 ASAP2 POM121 RASGRP3 FBXO42 MICAL3 DTX2 FLRT2 KIAA0930 CC2D1B PIKFYVE LDB3 POM121B | 1.02e-05 | 493 | 209 | 13 | 15368895 | |
| Pubmed | Early onset of Runx2 expression caused craniosynostosis, ectopic bone formation, and limb defects. | 1.17e-05 | 8 | 209 | 3 | 21807129 | |
| Pubmed | 1.23e-05 | 24 | 209 | 4 | 20826655 | ||
| Pubmed | 1.23e-05 | 24 | 209 | 4 | 11258795 | ||
| Pubmed | Expression of Groucho/TLE proteins during pancreas development. | 1.23e-05 | 24 | 209 | 4 | 18778483 | |
| Pubmed | PPP1R12B TAOK2 KMT2C STRN NFATC2 ANLN KMT2A DNMBP USP36 SLC4A7 CDC42BPA EP400 ARHGAP10 SYNE1 APC TRIOBP BUD13 DENND1A USP10 SETD5 SIPA1L1 CTNND2 AGRN CEP170B | 1.29e-05 | 1497 | 209 | 24 | 31527615 | |
| Pubmed | PDX1 ETV3 NFATC2 SEL1L3 DNMBP ZNF704 SLC4A7 TRIOBP NISCH SIPA1L1 CUX1 | 1.71e-05 | 371 | 209 | 11 | 15747579 | |
| Pubmed | GRIPAP1 TBKBP1 DNMBP CDC42BPA HDAC5 TRIOBP PIKFYVE SIPA1L1 CEP170B | 2.32e-05 | 251 | 209 | 9 | 29778605 | |
| Pubmed | 3.12e-05 | 60 | 209 | 5 | 20682791 | ||
| Pubmed | 3.27e-05 | 100 | 209 | 6 | 10048485 | ||
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 3.41e-05 | 11 | 209 | 3 | 15499562 | |
| Pubmed | 3.41e-05 | 11 | 209 | 3 | 33097091 | ||
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | 3.54e-05 | 265 | 209 | 9 | 19240061 | |
| Pubmed | A mouse model for endometrioid ovarian cancer arising from the distal oviduct. | 3.59e-05 | 2 | 209 | 2 | 24474556 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 15034051 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 10480912 | ||
| Pubmed | USP10 deubiquitinates RUNX1 and promotes proneural-to-mesenchymal transition in glioblastoma. | 3.59e-05 | 2 | 209 | 2 | 36949071 | |
| Pubmed | Co-expressing Pdx1 and Ngn3 induces few beta-like cells in the liver of mice. | 3.59e-05 | 2 | 209 | 2 | 17706592 | |
| Pubmed | Expression patterns and prognostic value of RUNX genes in kidney cancer. | 3.59e-05 | 2 | 209 | 2 | 34294773 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 26577046 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 19403666 | ||
| Pubmed | Runx1/3-driven adaptive endoplasmic reticulum stress pathways contribute to neurofibromagenesis. | 3.59e-05 | 2 | 209 | 2 | 36759572 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 10668804 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 18096667 | ||
| Pubmed | DOCK4 stimulates MUC2 production through its effect on goblet cell differentiation. | 3.59e-05 | 2 | 209 | 2 | 33559155 | |
| Pubmed | Tet3 regulates synaptic transmission and homeostatic plasticity via DNA oxidation and repair. | 3.59e-05 | 2 | 209 | 2 | 25915473 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 17609436 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 26883634 | ||
| Pubmed | Reprogramming of various cell types to a beta-like state by Pdx1, Ngn3 and MafA. | 3.59e-05 | 2 | 209 | 2 | 24312421 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 17360569 | ||
| Pubmed | Atf7ip Inhibits Osteoblast Differentiation via Negative Regulation of the Sp7 Transcription Factor. | 3.59e-05 | 2 | 209 | 2 | 36901736 | |
| Pubmed | UBR5 forms ligand-dependent complexes on chromatin to regulate nuclear hormone receptor stability. | 3.59e-05 | 2 | 209 | 2 | 37478846 | |
| Pubmed | Dietary induction of colonic tumors in a mouse model of sporadic colon cancer. | 3.59e-05 | 2 | 209 | 2 | 18829535 | |
| Pubmed | Advanced glycation end-products affect transcription factors regulating insulin gene expression. | 3.59e-05 | 2 | 209 | 2 | 20353756 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 33479171 | ||
| Pubmed | Specificity of MLL1 and TET3 CXXC domains towards naturally occurring cytosine modifications. | 3.59e-05 | 2 | 209 | 2 | 30352306 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 35468265 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 33968925 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 32340123 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 18794118 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 26053522 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 32483278 | ||
| Pubmed | Haploinsufficiency of the MLL and TOB2 genes in lymphoid malignancy. | 3.59e-05 | 2 | 209 | 2 | 19940862 | |
| Pubmed | Intestinal tumorigenesis is not affected by progesterone signaling in rodent models. | 3.59e-05 | 2 | 209 | 2 | 21818351 | |
| Pubmed | Neuroblastoma cell proliferation is sensitive to changes in levels of RUNX1 and RUNX3 protein. | 3.59e-05 | 2 | 209 | 2 | 21640801 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 18663147 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 19446949 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 26727107 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 11731260 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 19232344 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 11973276 | ||
| Pubmed | Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells. | 3.59e-05 | 2 | 209 | 2 | 23574718 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 38761506 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 23079602 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 32186954 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 21956756 | ||
| Pubmed | Coexpression of Runx1 and Runx3 in mechanoreceptive dorsal root ganglion neurons. | 3.59e-05 | 2 | 209 | 2 | 23378040 | |
| Pubmed | Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells. | 3.59e-05 | 2 | 209 | 2 | 15688019 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 26165797 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 30107050 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 12842190 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 19603429 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 21931641 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 37099375 | ||
| Interaction | YWHAG interactions | DOCK4 TNK1 SRRM1 KDM5B NCOA6 HIVEP2 RAPH1 SPEG FAM53C TAOK2 BORCS5 NFATC2 ANLN RABGAP1L KMT2A COBL DNMBP FOXO1 TICRR KIAA0930 SLC4A7 CDC42BPA HDAC5 APC DENND1A MICALL1 SIPA1L1 EXO1 PPIP5K1 SRRM2 SH3RF3 CEP170B DCP1A OTOG | 1.19e-07 | 1248 | 204 | 34 | int:YWHAG |
| Interaction | YWHAH interactions | DOCK4 TNK1 SRRM1 KDM5B NCOA6 HIVEP2 SPEG FAM53C BORCS5 ANLN RABGAP1L KMT2A COBL DNMBP FOXO1 TICRR KIAA0930 SLC4A7 CDC42BPA HDAC5 APC DENND1A MICALL1 SIPA1L1 EXO1 SRRM2 SH3RF3 CEP170B DCP1A OTOG | 7.43e-07 | 1102 | 204 | 30 | int:YWHAH |
| Interaction | YWHAB interactions | DOCK4 TNK1 KDM5B SPEG DAPK1 FAM53C ZYX BORCS5 NFATC2 ANLN KMT2A DNMBP FOXO1 TICRR KIAA0930 SLC4A7 CDC42BPA HDAC5 APC DENND1A MICALL1 SIPA1L1 EXO1 SRRM2 SH3RF3 CEP170B DCP1A OTOG | 1.38e-06 | 1014 | 204 | 28 | int:YWHAB |
| Interaction | TLE3 interactions | HIVEP2 POM121 UBR5 KMT2A CUL4B EBF3 CECR2 RUNX1 TLE2 TLE4 AUTS2 ELK3 RERE SRRM2 CUX1 SP7 | 1.53e-06 | 376 | 204 | 16 | int:TLE3 |
| Interaction | TOP3B interactions | NCOA6 HIVEP2 TBKBP1 UBE4B SPEG TAOK2 KMT2C COBL MICAL3 DTX2 DNMBP MYRF KIAA0930 CDC42BPA EP400 SZT2 POLDIP3 RTTN LRRK1 DENND1A MICALL1 PIKFYVE GAS2L1 TLNRD1 USP10 GAREM2 EPOP TRAPPC12 SETD5 BTBD7 CCDC34 NISCH ZFYVE26 AGRN CEP170B | 1.80e-06 | 1470 | 204 | 35 | int:TOP3B |
| Interaction | SFN interactions | TNK1 NCOA6 FAM53C ANLN RABGAP1L KMT2A COBL DTX2 DNMBP FOXO1 KIAA0930 SLC4A7 CDC42BPA HDAC5 APC DENND1A RNF126 SIPA1L1 EXO1 SRRM2 CEP170B DCP1A | 2.22e-06 | 692 | 204 | 22 | int:SFN |
| Interaction | RCOR1 interactions | KDM5B GRIPAP1 RAPH1 BCL3 DNAJC6 NFATC2 UBR5 RABGAP1L CSTPP1 CUL4B HDAC5 APC MIER1 ZFHX4 L3MBTL3 CUX1 DCP1A SP7 | 3.04e-06 | 494 | 204 | 18 | int:RCOR1 |
| Interaction | PRMT2 interactions | 3.98e-06 | 91 | 204 | 8 | int:PRMT2 | |
| Interaction | YWHAQ interactions | TNK1 KDM5B NCOA6 HIVEP2 SPEG DAPK1 FAM53C BORCS5 NFATC2 ANLN RASGRP3 KMT2A DNMBP FOXO1 TICRR KIAA0930 SLC4A7 CDC42BPA HDAC5 SRSF6 ARHGAP10 APC DENND1A SIPA1L1 EXO1 CEP170B DCP1A OTOG | 8.80e-06 | 1118 | 204 | 28 | int:YWHAQ |
| Interaction | YWHAE interactions | TNK1 KDM5B HIVEP2 FAM53C ZYX TAOK2 BORCS5 NFATC2 ANLN KMT2A DNMBP FOXO1 TICRR KIAA0930 SLC4A7 CDC42BPA HDAC5 SRSF6 APC DENND1A MICALL1 NISCH SIPA1L1 EXO1 SRRM2 SH3RF3 AGRN CEP170B DCP1A OTOG | 1.03e-05 | 1256 | 204 | 30 | int:YWHAE |
| Interaction | EN1 interactions | 1.63e-05 | 110 | 204 | 8 | int:EN1 | |
| Interaction | HDAC1 interactions | KDM5B RAPH1 KDM5C PDX1 BCL3 DNAJC6 NFATC2 UBR5 ANLN KMT2A CSTPP1 CUL4B USP36 CDC42BPA HDAC5 EP400 KLF6 APC RUNX1 RUNX3 MIER1 ZFHX4 TLE4 RERE L3MBTL3 CUX1 DCP1A | 2.10e-05 | 1108 | 204 | 27 | int:HDAC1 |
| Interaction | YWHAZ interactions | TNK1 KDM5B HIVEP2 RAPH1 SPEG FAM53C STRN BORCS5 NFATC2 ANLN KMT2A DNMBP FOXO1 EVL TICRR KIAA0930 SLC4A7 CDC42BPA HDAC5 APC DENND1A MICALL1 NISCH FHOD1 SIPA1L1 EXO1 TNS1 CEP170B DCP1A OTOG | 2.60e-05 | 1319 | 204 | 30 | int:YWHAZ |
| Interaction | EGR2 interactions | 6.34e-05 | 171 | 204 | 9 | int:EGR2 | |
| Interaction | NUP43 interactions | SRRM1 NCOA6 KDM5C POGZ SGO1 CSMD3 POM121 UBR5 KMT2A USP36 EP400 SZT2 APC BUD13 TRAPPC12 ATF7IP RERE SRRM2 | 7.01e-05 | 625 | 204 | 18 | int:NUP43 |
| Interaction | CTBP1 interactions | BCL3 NFATC2 KMT2A DTX2 CUL4B HDAC5 EP400 RTN4 APC RUNX1 TRAPPC12 NISCH ELK3 SRRM2 | 7.12e-05 | 406 | 204 | 14 | int:CTBP1 |
| Interaction | NCOR2 interactions | 8.29e-05 | 264 | 204 | 11 | int:NCOR2 | |
| Interaction | EHMT2 interactions | ETV3 POGZ SGO1 FOXO1 KLF6 MIER1 LIG1 ATF7IP ELK3 RERE CUX1 SP7 | 9.30e-05 | 315 | 204 | 12 | int:EHMT2 |
| Interaction | SH3KBP1 interactions | SRRM1 RAPH1 DAB1 ASAP2 POM121 ANLN DNMBP WIPF1 CBLB MICALL1 GAS2L1 SRRM2 | 9.30e-05 | 315 | 204 | 12 | int:SH3KBP1 |
| Interaction | KIF13B interactions | 1.01e-04 | 142 | 204 | 8 | int:KIF13B | |
| Interaction | VGLL4 interactions | 1.28e-04 | 26 | 204 | 4 | int:VGLL4 | |
| GeneFamily | Fibronectin type III domain containing | 2.20e-06 | 160 | 129 | 9 | 555 | |
| GeneFamily | LIM domain containing | 6.29e-05 | 59 | 129 | 5 | 1218 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 1.38e-03 | 8 | 129 | 2 | 837 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN | 4.23e-06 | 197 | 208 | 10 | M3438 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 4.34e-06 | 155 | 208 | 9 | M39246 | |
| Coexpression | GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN | UBE4B DNAJC6 PGR RASGRP3 PROB1 FOXO1 KIAA0930 CTNND2 SRRM2 CUX1 | 4.63e-06 | 199 | 208 | 10 | M6964 |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | KDM5B HIVEP2 DNAJC6 SYNE1 FCHO2 DENND1A GAS2L1 BTBD7 ZFYVE26 | 4.82e-06 | 157 | 208 | 9 | M7733 |
| Coexpression | GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP | 4.84e-06 | 200 | 208 | 10 | M302 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | DOCK4 HIVEP2 POGZ STRN UBR5 RABGAP1L DTX2 FOXO1 CBLB PIKFYVE TLE4 AUTS2 | 5.48e-06 | 300 | 208 | 12 | M8702 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK4 KDM5B HIVEP2 DAPK1 ASAP2 UBR5 RABGAP1L MICAL3 FLRT2 DNMBP SLC4A7 CDC42BPA KLF6 APC RUNX1 CBLB PIKFYVE TLE4 SIPA1L1 CUX1 | 1.75e-05 | 856 | 208 | 20 | M4500 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | HIVEP2 ZYX KMT2C NFATC2 UBR5 RABGAP1L SEL1L3 KMT2A BIN2 FOXO1 EVL SLC4A7 WIPF1 EP400 KLF6 SYNE1 RUNX3 CBLB MIER1 PIKFYVE ZBTB44 SETD5 ATF7IP FHOD1 AUTS2 LY9 PIK3R5 DCP1A | 2.09e-05 | 1492 | 208 | 28 | M40023 |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 2.16e-05 | 145 | 208 | 8 | M1810 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | HIVEP2 DAPK1 ASAP2 UBR5 MICAL3 DNMBP SLC4A7 CDC42BPA KLF6 RUNX1 CBLB PIKFYVE TLE4 CUX1 | 2.35e-05 | 466 | 208 | 14 | M13522 |
| Coexpression | GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_UP | 2.97e-05 | 197 | 208 | 9 | M3343 | |
| Coexpression | HINATA_NFKB_TARGETS_KERATINOCYTE_DN | 3.03e-05 | 23 | 208 | 4 | M1959 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | TOB2 UBE4B DAB1 PTPRG WIPF1 ARHGAP10 RUNX1 TENM4 ROBO2 SRRM2 TNS1 CUX1 EPHA8 | 3.16e-05 | 417 | 208 | 13 | M39224 |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN | 3.21e-05 | 199 | 208 | 9 | M7319 | |
| Coexpression | GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | UBE4B FAM120AOS PGR RASGRP3 FOXO1 KIAA0930 ATF7IP CTNND2 SRRM2 | 3.34e-05 | 200 | 208 | 9 | M291 |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP | 3.34e-05 | 200 | 208 | 9 | M7417 | |
| Coexpression | KIM_WT1_TARGETS_8HR_UP | 5.92e-05 | 167 | 208 | 8 | M8857 | |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 6.44e-05 | 169 | 208 | 8 | M39230 | |
| Coexpression | GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN | 1.04e-04 | 181 | 208 | 8 | M8662 | |
| Coexpression | HOEBEKE_LYMPHOID_STEM_CELL_UP | 1.26e-04 | 97 | 208 | 6 | M14698 | |
| Coexpression | GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_UP | 1.51e-04 | 191 | 208 | 8 | M4926 | |
| Coexpression | GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_UP | 1.93e-04 | 198 | 208 | 8 | M4539 | |
| Coexpression | GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_DN | 1.93e-04 | 198 | 208 | 8 | M5545 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | DOCK4 KDM5B SPEG PPP1R12B KLHL29 SSC5D STRN RABGAP1L MICAL3 FLRT2 MYRF KIAA0930 HDAC5 SYNE1 RTN4 RTTN GAREM2 BRI3BP NISCH TJAP1 TNS1 | 1.96e-04 | 1102 | 208 | 21 | M2369 |
| Coexpression | GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP | 1.99e-04 | 199 | 208 | 8 | M6198 | |
| Coexpression | GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_UP | 1.99e-04 | 199 | 208 | 8 | M6420 | |
| Coexpression | GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_DN | 1.99e-04 | 199 | 208 | 8 | M7779 | |
| Coexpression | GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 1.99e-04 | 199 | 208 | 8 | M5359 | |
| Coexpression | GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 1.99e-04 | 199 | 208 | 8 | M5357 | |
| Coexpression | GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_UP | 1.99e-04 | 199 | 208 | 8 | M5620 | |
| Coexpression | GSE24726_WT_VS_E2_2_KO_PDC_DAY6_POST_DELETION_DN | 2.06e-04 | 200 | 208 | 8 | M8056 | |
| Coexpression | GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN | 2.06e-04 | 200 | 208 | 8 | M304 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_12H_BMDC_UP | 2.06e-04 | 200 | 208 | 8 | M3948 | |
| Coexpression | GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_DN | 2.06e-04 | 200 | 208 | 8 | M6552 | |
| Coexpression | GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_UP | 2.06e-04 | 200 | 208 | 8 | M6795 | |
| Coexpression | GSE40666_WT_VS_STAT1_KO_CD8_TCELL_UP | 2.06e-04 | 200 | 208 | 8 | M9205 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | IRX5 SALL3 DAB1 DNAJC6 KLHL29 PTPRG FLRT2 SGIP1 APC RUNX1 RUNX3 MIER1 ZFHX4 TLE4 SERTAD4 AUTS2 ROBO2 VGLL4 CTNND2 L3MBTL3 AGRN CUX1 | 4.12e-06 | 769 | 201 | 22 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500 | 2.19e-05 | 89 | 201 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k2 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | DOCK4 DAPK1 KMT2C RABGAP1L FOXO1 RUNX1 DENND1A SIPA1L1 RERE PIK3R5 CUX1 | 2.07e-09 | 193 | 209 | 11 | 779276e775cb2492e8dd36436295a536084a6415 |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | IL12RB2 NFATC2 RABGAP1L BIN2 SLC4A7 WIPF1 RUNX3 CBLB ATF7IP PIK3R5 | 2.08e-08 | 187 | 209 | 10 | f4e8e0eba58da89b56587667555a5d4754e108c7 |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.25e-08 | 196 | 209 | 10 | 54f4cf778f95a9ff662e5c7520916a25e605bf95 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.17e-08 | 163 | 209 | 9 | 8f24cef152f5965727bbeee116bd26c75cbba82a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-07 | 175 | 209 | 9 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.30e-07 | 184 | 209 | 9 | cef3ee2a4a0af961aa3b4c92150d423e841ae8c1 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.52e-07 | 186 | 209 | 9 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | IPF-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 2.63e-07 | 187 | 209 | 9 | af1327559f7e01bec070881cae52834917c3da65 | |
| ToppCell | NS-critical-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.01e-07 | 190 | 209 | 9 | 7be0f2ff86ca8500a43e0d44e5e292530f9ba0bb | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.01e-07 | 190 | 209 | 9 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.15e-07 | 191 | 209 | 9 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.59e-07 | 194 | 209 | 9 | d2bafd31bb8333f66b6c714944bceb2f1aa11740 | |
| ToppCell | COVID-19-kidney-T-cells-1|kidney / Disease (COVID-19 only), tissue and cell type | 4.08e-07 | 197 | 209 | 9 | 9bb7faf4ef63cca4d06c60e6c05a9616fdb6b98e | |
| ToppCell | critical-Epithelial-FOXN4+|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.26e-07 | 198 | 209 | 9 | 6b160b3d6a2c1b1641c2c7dcec1a7ef38411fec9 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.26e-07 | 198 | 209 | 9 | 1e1ea54f0c234f3b6d29064c4881d8a0c0949a75 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.44e-07 | 199 | 209 | 9 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.63e-07 | 200 | 209 | 9 | c6c2b39359c65c9444987d02d1c899dff2ad1366 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.63e-07 | 200 | 209 | 9 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.14e-06 | 179 | 209 | 8 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-06 | 180 | 209 | 8 | da723df348d7b8449bb1124f23fe6fa706412adb | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-06 | 180 | 209 | 8 | 50758b1e7be2e43f83c10ab106900c067e61f5f7 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-06 | 180 | 209 | 8 | 5b146a94708b3c3610542a4d0925f3f7a2b19185 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.33e-06 | 181 | 209 | 8 | 25915e2500430a902db37d79a749ce2990b69810 | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.53e-06 | 183 | 209 | 8 | 3c4153479fc4ab2d073d92cee120480015555914 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.74e-06 | 185 | 209 | 8 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 2.97e-06 | 187 | 209 | 8 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Control-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 2.97e-06 | 187 | 209 | 8 | 4e64be635f445276e71f2937f33f041c3a4204ab | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.97e-06 | 187 | 209 | 8 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.09e-06 | 188 | 209 | 8 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.21e-06 | 189 | 209 | 8 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-06 | 189 | 209 | 8 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-06 | 189 | 209 | 8 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.21e-06 | 189 | 209 | 8 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | COPD-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 3.34e-06 | 190 | 209 | 8 | 1e85ee686ff6dd27c69415d524d54fa825b1daad | |
| ToppCell | COVID-19-lung-CD4+_Treg|lung / Disease (COVID-19 only), tissue and cell type | 3.47e-06 | 191 | 209 | 8 | 73ea3078c1f55cd47e4d99e77b3ce4ff17549d49 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.47e-06 | 191 | 209 | 8 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-06 | 191 | 209 | 8 | 2c51850f5c559d665b8a27a12b75af9ed58dffe1 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.47e-06 | 191 | 209 | 8 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | COPD-Lymphoid|COPD / Disease state, Lineage and Cell class | 3.61e-06 | 192 | 209 | 8 | 064fefb8212fadab0ff441f4bf643559b7fdb25d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.61e-06 | 192 | 209 | 8 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.75e-06 | 193 | 209 | 8 | 194e7fa00a50cc4e026987b715323d125d79594e | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.75e-06 | 193 | 209 | 8 | 549a0b750c860b615aff767ad04c9a9d20f802f0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.89e-06 | 194 | 209 | 8 | 5cd72330c9d9bb21b6c9d5d35085eade101486d1 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD8-Tem/emra_CD8|bone_marrow / Manually curated celltypes from each tissue | 4.20e-06 | 196 | 209 | 8 | f23c33ad10f933250be98e8389a9aa278e876f96 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.36e-06 | 197 | 209 | 8 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.36e-06 | 197 | 209 | 8 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-06 | 197 | 209 | 8 | cd509e49bbdbf991cc5913960ff3ef275ad40628 | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.36e-06 | 197 | 209 | 8 | ee8f7def9d5af7b1e636830a4ea1da158d02f25a | |
| ToppCell | T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 4.53e-06 | 198 | 209 | 8 | 1ca6cd8e75891fdfaddbb4a7342eec9ca4d11e5d | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.53e-06 | 198 | 209 | 8 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.53e-06 | 198 | 209 | 8 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.70e-06 | 199 | 209 | 8 | 056a28c36cd58dc695a5ae6f29b62135d6aad819 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.70e-06 | 199 | 209 | 8 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.87e-06 | 200 | 209 | 8 | 8474e5d031d25bfb8461d39fa2053da01a6304fc | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.87e-06 | 200 | 209 | 8 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.87e-06 | 200 | 209 | 8 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.87e-06 | 200 | 209 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.87e-06 | 200 | 209 | 8 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.87e-06 | 200 | 209 | 8 | 9de4d6ebb7e9bee5d811519eb05913ef30f70786 | |
| ToppCell | facs-Aorta-Heart-3m-Epithelial-epithelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-06 | 151 | 209 | 7 | 0de76acd1b204345dce7f33be2a1ed9fbe9e6da0 | |
| ToppCell | facs-Aorta-Heart-3m-Epithelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-06 | 151 | 209 | 7 | 20b9c8fb966c5d62ff909cc4a4616b109b78cdca | |
| ToppCell | facs-Aorta-Heart-3m-Epithelial|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-06 | 151 | 209 | 7 | bee48137d1f5f27a24571a59c835284651d38538 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.27e-05 | 164 | 209 | 7 | 519ab4fe885dfe4c50846f346a062acc2cb44299 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.37e-05 | 166 | 209 | 7 | 26f3d5e5e30b63b09b89cda23c423d12d887631f | |
| ToppCell | Severe-Lymphoid-NK-CD8_T|Severe / Condition, Lineage, Cell class and cell subclass | 1.43e-05 | 167 | 209 | 7 | 8d41015871616ab7eced5104cd8f70d0efe504f2 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 172 | 209 | 7 | cabe7b4131d72da87d3caacd8cced3a4f2cbef53 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.79e-05 | 173 | 209 | 7 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-05 | 173 | 209 | 7 | afa6bb19df52541d8d17cbfac9cbdd18a5f3632d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-05 | 175 | 209 | 7 | b80fe906043b3cb0b3ba761aadc9dc1c364aa1bf | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-05 | 175 | 209 | 7 | 067c7d89cfdf6ebf70692df64b9b79d752f093dd | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.00e-05 | 176 | 209 | 7 | a85ad8b4815fde72edd5c900e882a0bc04033ea8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.07e-05 | 177 | 209 | 7 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 178 | 209 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 178 | 209 | 7 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.15e-05 | 178 | 209 | 7 | c77a1d1a9aef0ab51b4408b9e84f201219788ca2 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-05 | 179 | 209 | 7 | 142457c98656ed389461e081e0e6d03e86d2fb1a | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.23e-05 | 179 | 209 | 7 | ca70a5518c5a5392e088c103e0cb44aa084f5332 | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.23e-05 | 179 | 209 | 7 | c451b074b04eb5d6c575c6abaedda579c6744bbf | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 2.31e-05 | 180 | 209 | 7 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 181 | 209 | 7 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.48e-05 | 182 | 209 | 7 | 1c1a687f728341c209b048b6715bcddd0ac20069 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 182 | 209 | 7 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.48e-05 | 182 | 209 | 7 | 97bb07478f56a937b490fba121ee603db64134a1 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.48e-05 | 182 | 209 | 7 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.57e-05 | 183 | 209 | 7 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-05 | 183 | 209 | 7 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.57e-05 | 183 | 209 | 7 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-Treg|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.57e-05 | 183 | 209 | 7 | f478dfa231fc1b12ead0183cc9d22077cdf43d1f | |
| ToppCell | nucseq-Immune-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.66e-05 | 184 | 209 | 7 | 911658e7bb499c1bbc8419eec8ff88729bc39a75 | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-T_NK_proliferative|Bac-SEP / Disease, Lineage and Cell Type | 2.66e-05 | 184 | 209 | 7 | 848d05afd5a2ef61fb8a09c0f5fa2a56fd5c160b | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.66e-05 | 184 | 209 | 7 | 942b58ae7172bb5f97e55b032db9329d161854af | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.75e-05 | 185 | 209 | 7 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | Control-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations) | 2.75e-05 | 185 | 209 | 7 | 02ab64c0166c0646d1d4c6ed110ef0b75a1096d0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Neuronal-Interneuron|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 2.77e-05 | 125 | 209 | 6 | eafc39072467e209c9fe3a4fa41cb09507a42e82 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 186 | 209 | 7 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor | 2.95e-05 | 187 | 209 | 7 | 1e52d3d9d664c813d859b5b75e4c07b218818f95 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.95e-05 | 187 | 209 | 7 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-05 | 188 | 209 | 7 | 1cd5a4d744bd3777246958ea5eb94388a5cbad81 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-05 | 188 | 209 | 7 | c32d023a69b6da79687ff8fa7485e7499db57046 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.05e-05 | 188 | 209 | 7 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| Drug | Seneciphylline [480-81-9]; Down 200; 12uM; PC3; HT_HG-U133A | TBKBP1 KDM5C ZYX TAOK2 POLDIP3 APC RUNX1 GAS2L1 RERE LY9 AGRN | 1.74e-06 | 196 | 205 | 11 | 4238_DN |
| Drug | Benfluorex hydrochloride [23642-66-2]; Down 200; 10.4uM; PC3; HT_HG-U133A | TNK1 SPEG TAOK2 WIPF1 EP400 ARHGAP10 POLDIP3 RUNX1 CREB3L1 TENM4 TLE4 | 1.83e-06 | 197 | 205 | 11 | 6727_DN |
| Drug | Moxisylyte hydrochoride [964-52-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A | TNK1 PCYT1A TOB2 PPP1R12B DNAJC6 RABGAP1L CDC42BPA RUNX1 CBLB MICALL1 SRRM2 | 2.12e-06 | 200 | 205 | 11 | 7015_DN |
| Drug | thioridazine hydrochloride; Up 200; 10uM; HL60; HT_HG-U133A | 5.69e-06 | 180 | 205 | 10 | 1171_UP | |
| Drug | Perhexiline maleate [6724-53-4]; Up 200; 10.2uM; HL60; HT_HG-U133A | BCL3 FLRT2 FOXO1 SLC4A7 KLF6 POLDIP3 SYNE1 RUNX1 GAS2L1 RERE | 5.69e-06 | 180 | 205 | 10 | 2410_UP |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | HIVEP2 CEACAM3 FBXO42 HDAC5 KLF6 RUNX1 CBLB TLE4 TJAP1 CTNND2 | 9.16e-06 | 190 | 205 | 10 | 6956_UP |
| Drug | Clemastine fumarate [14976-57-9]; Up 200; 8.6uM; HL60; HT_HG-U133A | DMBT1 FOXO1 RUNX1 MICALL1 GAS2L1 BTBD7 TJAP1 ZFYVE26 SRRM2 INPP5J | 1.05e-05 | 193 | 205 | 10 | 2412_UP |
| Drug | Indomethacin [53-86-1]; Up 200; 11.2uM; HL60; HT_HG-U133A | PPP1R12B TAOK2 FLRT2 MYRF FOXO1 RUNX1 MICALL1 RERE TNS1 ZNF646 | 1.10e-05 | 194 | 205 | 10 | 2377_UP |
| Drug | Sulfachloropyridazine [80-32-0]; Down 200; 14uM; PC3; HT_HG-U133A | 1.15e-05 | 195 | 205 | 10 | 4326_DN | |
| Drug | Clomipramine hydrochloride [17321-77-6]; Up 200; 11.4uM; HL60; HG-U133A | KDM5C ADM2 ZNF185 BCL3 SULT2B1 CUL4B EVL CDC42BPA HDAC5 KLF6 | 1.20e-05 | 196 | 205 | 10 | 1566_UP |
| Drug | Imipramine hydrochloride [113-52-0]; Up 200; 12.6uM; HL60; HT_HG-U133A | TOB2 HIVEP2 KMT2A SLC4A7 CDC42BPA LRRK1 RUNX1 GAS2L1 BTBD7 SIPA1L1 | 1.20e-05 | 196 | 205 | 10 | 1849_UP |
| Drug | Aminophylline [317-34-0]; Down 200; 9.6uM; PC3; HT_HG-U133A | STRN KIAA0930 SLC4A7 EP400 KLF6 ARHGAP10 CREB3L1 TNS1 AGRN CUX1 | 1.20e-05 | 196 | 205 | 10 | 6295_DN |
| Drug | Foliosidine [2520-38-9]; Down 200; 13uM; PC3; HT_HG-U133A | 1.26e-05 | 197 | 205 | 10 | 4295_DN | |
| Drug | Sulfathiazole [72-14-0]; Down 200; 15.6uM; MCF7; HT_HG-U133A | HIVEP2 ZYX TAOK2 SULT2B1 USP36 FOXO1 KIAA0930 KLF6 BTBD7 CTNND2 | 1.26e-05 | 197 | 205 | 10 | 1463_DN |
| Drug | Ifosfamide [3778-73-2]; Up 200; 15.4uM; PC3; HT_HG-U133A | 1.31e-05 | 198 | 205 | 10 | 5805_UP | |
| Drug | Foliosidine [2520-38-9]; Up 200; 13uM; PC3; HT_HG-U133A | 1.31e-05 | 198 | 205 | 10 | 3739_UP | |
| Drug | 0225151-0000 [351320-15-5]; Down 200; 10uM; MCF7; HT_HG-U133A | CEACAM3 CDC42BPA WIPF1 SYNE1 APC MICALL1 ELK3 LY9 PIK3R5 ZNF646 | 1.31e-05 | 198 | 205 | 10 | 6384_DN |
| Drug | Griseofulvin [126-07-8]; Up 200; 11.2uM; PC3; HT_HG-U133A | TNK1 CEACAM3 DMBT1 CDC42BPA NRG2 LRRK1 RUNX3 TENM4 BTBD7 INPP5J | 1.37e-05 | 199 | 205 | 10 | 7363_UP |
| Drug | Ketorolac tromethamine [74103-07-4]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.37e-05 | 199 | 205 | 10 | 6489_UP | |
| Drug | Antipyrine [60-80-0]; Up 200; 21.2uM; HL60; HG-U133A | ADM2 DAPK1 POGZ BCL3 SLC4A7 CDC42BPA ARHGAP10 GAS2L1 MUC2 TNS1 | 1.37e-05 | 199 | 205 | 10 | 1989_UP |
| Drug | Iodipamide [606-17-7]; Down 200; 3.6uM; MCF7; HT_HG-U133A | STRN RABGAP1L APC RUNX1 RNF126 MICALL1 TLE4 SIPA1L1 CTNND2 AGRN | 1.43e-05 | 200 | 205 | 10 | 5510_DN |
| Drug | 2,4,4'-trichlorobiphenyl | KDM5B RAPH1 ADM2 DAB1 DAPK1 SGO1 CSMD3 DNAJC6 PGR EBF2 FNDC1 SULT2B1 ROBO4 TICRR CDC42BPA SRSF6 EP400 EBF3 CECR2 TRIOBP HES3 MSH4 LDB3 ZFHX4 EXO1 ROBO2 RERE SH3RF3 ZNF646 | 2.75e-05 | 1411 | 205 | 29 | ctd:C081766 |
| Drug | 2,4,5,2',5'-pentachlorobiphenyl | KDM5B RAPH1 ADM2 DAB1 DAPK1 SGO1 CSMD3 DNAJC6 PGR EBF2 FNDC1 SULT2B1 ROBO4 TICRR CDC42BPA SRSF6 EP400 EBF3 CECR2 TRIOBP HES3 MSH4 LDB3 ZFHX4 EXO1 ROBO2 RERE SH3RF3 ZNF646 | 4.02e-05 | 1441 | 205 | 29 | ctd:C009828 |
| Drug | Tribenoside [10310-32-4]; Up 200; 8.4uM; HL60; HT_HG-U133A | 4.59e-05 | 184 | 205 | 9 | 2946_UP | |
| Drug | Rescinnamin [24815-24-5]; Up 200; 6.4uM; HL60; HT_HG-U133A | DOCK4 SLC4A7 CDC42BPA RUNX1 ZFHX4 SIPA1L1 SRRM2 CEP170B CUX1 | 4.99e-05 | 186 | 205 | 9 | 2130_UP |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Up 200; 11uM; HL60; HT_HG-U133A | 5.42e-05 | 188 | 205 | 9 | 3046_UP | |
| Drug | C768-0445; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 5.65e-05 | 189 | 205 | 9 | 973_UP | |
| Drug | Salbutamol [18559-94-9]; Down 200; 16.8uM; PC3; HT_HG-U133A | 6.13e-05 | 191 | 205 | 9 | 7376_DN | |
| Drug | Dihydroergotamine tartrate [5989-77-5]; Down 200; 3uM; PC3; HT_HG-U133A | KDM5B UBE4B PPP1R12B BCL3 FBXO42 ARHGAP10 RUNX1 RNF126 BTBD7 | 6.38e-05 | 192 | 205 | 9 | 2081_DN |
| Drug | troglitazone; Down 200; 10uM; HL60; HT_HG-U133A | 6.38e-05 | 192 | 205 | 9 | 1173_DN | |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Up 200; 10.6uM; PC3; HT_HG-U133A | 6.38e-05 | 192 | 205 | 9 | 7382_UP | |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; PC3; HT_HG-U133A | 6.64e-05 | 193 | 205 | 9 | 4202_DN | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 10uM; PC3; HT_HG-U133A | 6.91e-05 | 194 | 205 | 9 | 4559_DN | |
| Drug | Acetaminophen [103-90-2]; Down 200; 26.4uM; MCF7; HT_HG-U133A | 6.91e-05 | 194 | 205 | 9 | 5384_DN | |
| Drug | Indapamide [26807-65-8]; Down 200; 10.6uM; PC3; HT_HG-U133A | 6.91e-05 | 194 | 205 | 9 | 4335_DN | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 1uM; PC3; HT_HG-U133A | 6.91e-05 | 194 | 205 | 9 | 4291_DN | |
| Drug | Oxamniquine [21738-42-1]; Up 200; 14.4uM; HL60; HT_HG-U133A | 7.19e-05 | 195 | 205 | 9 | 2924_UP | |
| Drug | Pyrantel tartrate [33401-94-4]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 7.19e-05 | 195 | 205 | 9 | 2260_UP | |
| Drug | Pentamidine isethionate [140-64-7]; Down 200; 6.8uM; HL60; HT_HG-U133A | 7.47e-05 | 196 | 205 | 9 | 2473_DN | |
| Drug | Amrinone [60719-84-8]; Up 200; 21.4uM; HL60; HT_HG-U133A | 7.47e-05 | 196 | 205 | 9 | 2724_UP | |
| Drug | Domperidone maleate; Down 200; 7.4uM; HL60; HT_HG-U133A | 7.47e-05 | 196 | 205 | 9 | 1301_DN | |
| Drug | Oxybenzone [131-57-7]; Down 200; 17.6uM; PC3; HT_HG-U133A | 7.47e-05 | 196 | 205 | 9 | 6309_DN | |
| Drug | Demecarium bromide [56-94-0]; Up 200; 5.6uM; MCF7; HT_HG-U133A | 7.47e-05 | 196 | 205 | 9 | 6269_UP | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; PC3; HT_HG-U133A | IL12RB2 KLHL29 COBL CDC42BPA PRR36 ARHGAP10 LRRK1 CREB3L1 INPP5J | 7.77e-05 | 197 | 205 | 9 | 4299_UP |
| Drug | Vincamine [1617-90-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A | TOB2 TAOK2 RABGAP1L KMT2A KIAA0930 CDC42BPA APC SIPA1L1 RERE | 7.77e-05 | 197 | 205 | 9 | 3865_DN |
| Drug | PMME | 8.07e-05 | 2 | 205 | 2 | CID000439436 | |
| Drug | Mianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 8.08e-05 | 198 | 205 | 9 | 5786_DN | |
| Drug | Tomatidine [77-59-8]; Up 200; 9.6uM; HL60; HG-U133A | 8.08e-05 | 198 | 205 | 9 | 1754_UP | |
| Drug | Scoulerine [6451-73-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 8.08e-05 | 198 | 205 | 9 | 2891_UP | |
| Drug | estradiol, USP; Up 200; 0.01uM; PC3; HT_HG-U133A | 8.08e-05 | 198 | 205 | 9 | 1241_UP | |
| Drug | Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; PC3; HT_HG-U133A | 8.08e-05 | 198 | 205 | 9 | 5799_DN | |
| Drug | Amrinone [60719-84-8]; Down 200; 21.4uM; HL60; HT_HG-U133A | 8.08e-05 | 198 | 205 | 9 | 2724_DN | |
| Drug | Dehydrocholic acid [81-23-2]; Up 200; 9.6uM; PC3; HG-U133A | 8.08e-05 | 198 | 205 | 9 | 1940_UP | |
| Drug | Niridazole [61-57-4]; Up 200; 18.6uM; PC3; HT_HG-U133A | 8.08e-05 | 198 | 205 | 9 | 4621_UP | |
| Drug | Cefaclor [70356-03-5]; Down 200; 10.4uM; PC3; HT_HG-U133A | 8.08e-05 | 198 | 205 | 9 | 6622_DN | |
| Drug | Mefexamide hydrochloride [3413-64-7]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 8.08e-05 | 198 | 205 | 9 | 2284_UP | |
| Drug | Flucytosine [2022-85-7]; Up 200; 31uM; HL60; HT_HG-U133A | 8.40e-05 | 199 | 205 | 9 | 3073_UP | |
| Drug | Hydroquinine hydrobromide hydrate [304695-81-6]; Down 200; 9.4uM; PC3; HT_HG-U133A | 8.40e-05 | 199 | 205 | 9 | 5789_DN | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; HL60; HT_HG-U133A | 8.40e-05 | 199 | 205 | 9 | 1337_DN | |
| Drug | Isoconazole [27523-40-6]; Up 200; 9.6uM; PC3; HT_HG-U133A | 8.40e-05 | 199 | 205 | 9 | 5857_UP | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A | HIVEP2 FBXO42 KIAA0930 ARHGAP10 TEAD3 MICALL1 BTBD7 CTNND2 CEP170B | 8.40e-05 | 199 | 205 | 9 | 1648_DN |
| Drug | Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; PC3; HT_HG-U133A | 8.73e-05 | 200 | 205 | 9 | 7129_DN | |
| Drug | Pergolide mesylate [66104-23-2]; Up 200; 9.8uM; HL60; HT_HG-U133A | 1.35e-04 | 166 | 205 | 8 | 2403_UP | |
| Drug | Colchicine [64-86-8]; Up 200; 10uM; HL60; HG-U133A | 1.65e-04 | 171 | 205 | 8 | 1598_UP | |
| Drug | Ciclopirox ethanolamine [41621-49-2]; Up 200; 15uM; HL60; HT_HG-U133A | 1.86e-04 | 174 | 205 | 8 | 2456_UP | |
| Drug | geldanamycin; Up 200; 1uM; HL60; HT_HG-U133A | 2.26e-04 | 179 | 205 | 8 | 1169_UP | |
| Drug | C05674 | 2.41e-04 | 3 | 205 | 2 | CID000440755 | |
| Drug | TiCl4 | 2.43e-04 | 14 | 205 | 3 | CID000024193 | |
| Drug | AC1L9KQC | 2.43e-04 | 14 | 205 | 3 | CID000447330 | |
| Drug | Monensin sodium salt [22373-78-0]; Up 200; 5.8uM; PC3; HT_HG-U133A | 2.82e-04 | 185 | 205 | 8 | 7402_UP | |
| Drug | Withaferin A [5119-48-2]; Down 200; 1uM; PC3; HT_HG-U133A | 2.93e-04 | 186 | 205 | 8 | 3819_DN | |
| Drug | glycerophosphorylethanolamine | 3.00e-04 | 36 | 205 | 4 | CID000123874 | |
| Drug | 17-AAG; Down 200; 1uM; PC3; HT_HG-U133A | 3.15e-04 | 188 | 205 | 8 | 1218_DN | |
| Drug | oxaprozin; Up 200; 300uM; MCF7; HT_HG-U133A_EA | 3.38e-04 | 190 | 205 | 8 | 863_UP | |
| Drug | Naftopidil dihydrochloride [57149-08-3]; Up 200; 8.6uM; HL60; HT_HG-U133A | 3.38e-04 | 190 | 205 | 8 | 2911_UP | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 3.50e-04 | 191 | 205 | 8 | 1057_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.50e-04 | 191 | 205 | 8 | 1063_DN | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.50e-04 | 191 | 205 | 8 | 1008_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.50e-04 | 191 | 205 | 8 | 5204_DN | |
| Drug | 3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; MCF7; HT_HG-U133A | 3.62e-04 | 192 | 205 | 8 | 3382_DN | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HG-U133A | 3.62e-04 | 192 | 205 | 8 | 611_DN | |
| Drug | Dobutamine hydrochloride [49745-95-1]; Up 200; 11.8uM; HL60; HG-U133A | 3.62e-04 | 192 | 205 | 8 | 1589_UP | |
| Drug | Ergocryptine-alpha [511-09-1]; Up 200; 7uM; HL60; HT_HG-U133A | 3.62e-04 | 192 | 205 | 8 | 2572_UP | |
| Drug | Nitrendipine [39562-70-4]; Up 200; 11uM; HL60; HT_HG-U133A | 3.62e-04 | 192 | 205 | 8 | 3087_UP | |
| Drug | Ketoprofen [22071-15-4]; Down 200; 15.8uM; PC3; HT_HG-U133A | 3.75e-04 | 193 | 205 | 8 | 4286_DN | |
| Drug | Letrozole [112809-51-5]; Down 200; 14uM; PC3; HT_HG-U133A | 3.75e-04 | 193 | 205 | 8 | 4240_DN | |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | 3.88e-04 | 194 | 205 | 8 | 1180_UP | |
| Drug | 5248896; Up 200; 11uM; MCF7; HT_HG-U133A_EA | 3.88e-04 | 194 | 205 | 8 | 955_UP | |
| Drug | semustine; Down 200; 100uM; PC3; HT_HG-U133A | 3.88e-04 | 194 | 205 | 8 | 7492_DN | |
| Drug | Indomethacin [53-86-1]; Down 200; 11.2uM; PC3; HT_HG-U133A | 3.88e-04 | 194 | 205 | 8 | 5049_DN | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A | 3.88e-04 | 194 | 205 | 8 | 1642_DN | |
| Drug | SC 19220; Up 200; 10uM; PC3; HT_HG-U133A | 3.88e-04 | 194 | 205 | 8 | 7065_UP | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 3.88e-04 | 194 | 205 | 8 | 3354_DN | |
| Drug | Nadide [53-84-9]; Up 200; 6uM; PC3; HT_HG-U133A | 3.88e-04 | 194 | 205 | 8 | 5873_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 3.88e-04 | 194 | 205 | 8 | 2993_UP | |
| Drug | Quinethazone [73-49-4]; Down 200; 13.8uM; PC3; HT_HG-U133A | 3.88e-04 | 194 | 205 | 8 | 4529_DN | |
| Drug | Delcorine; Down 200; 8.4uM; MCF7; HT_HG-U133A | 4.02e-04 | 195 | 205 | 8 | 4737_DN | |
| Drug | ST021200; Up 200; 10uM; PC3; HT_HG-U133A | 4.02e-04 | 195 | 205 | 8 | 7559_UP | |
| Drug | Probucol [23288-49-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 4.02e-04 | 195 | 205 | 8 | 5261_UP | |
| Drug | Azlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; HL60; HT_HG-U133A | 4.02e-04 | 195 | 205 | 8 | 2727_DN | |
| Disease | Leukemia, Myelocytic, Acute | 3.49e-07 | 173 | 202 | 10 | C0023467 | |
| Disease | intellectual disability (implicated_via_orthology) | 8.50e-07 | 75 | 202 | 7 | DOID:1059 (implicated_via_orthology) | |
| Disease | urate measurement, bone density | UBE4B PSMG3-AS1 STRN FNDC1 BORCS5 PTPRG RABGAP1L FBXO42 VAX2 DMBT1 ATG9B SYNE1 RUNX1 DENND1A CTNND2 SH3RF3 TNXB | 1.43e-06 | 619 | 202 | 17 | EFO_0003923, EFO_0004531 |
| Disease | cortical surface area measurement | RAPH1 NFILZ PPP1R12B DAB1 DAPK1 KLHL29 HOXB1 STRN FBXO42 TICRR APC TRIOBP FCHO2 DENND1A EPOP TLE4 AUTS2 ROBO2 ELK3 RERE L3MBTL3 TNS1 SH3RF3 TNXB CUX1 SP7 | 1.90e-06 | 1345 | 202 | 26 | EFO_0010736 |
| Disease | mean arterial pressure | GRIPAP1 DAPK1 EBF2 NFATC2 USP36 MEF2B SLC4A7 SGIP1 SZT2 JPH2 RUNX3 CREB3L1 AUTS2 RERE TNS1 | 2.04e-06 | 499 | 202 | 15 | EFO_0006340 |
| Disease | Acute Myeloid Leukemia, M1 | 2.49e-06 | 125 | 202 | 8 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 2.49e-06 | 125 | 202 | 8 | C1879321 | |
| Disease | free androgen index | PCYT1A HGFAC UBE4B DGKB PTPRG SKOR2 DNMBP ZNF704 ARHGAP10 ZFHX4 L3MBTL3 CUX1 | 1.15e-05 | 374 | 202 | 12 | EFO_0007005 |
| Disease | Carcinoma, Granular Cell | 1.58e-05 | 116 | 202 | 7 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.58e-05 | 116 | 202 | 7 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.58e-05 | 116 | 202 | 7 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.58e-05 | 116 | 202 | 7 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.58e-05 | 116 | 202 | 7 | C0205641 | |
| Disease | Adenocarcinoma | 1.58e-05 | 116 | 202 | 7 | C0001418 | |
| Disease | serum gamma-glutamyl transferase measurement | HGFAC PDX1 CSMD3 ZYX STRN POM121 FBXO42 KMT2A MICAL3 DNMBP TRIM46 SGIP1 CDC42BPA ARHGAP10 TRIOBP CBLB TENM4 L3MBTL3 | 6.30e-05 | 914 | 202 | 18 | EFO_0004532 |
| Disease | cholesteryl ester 18:2 measurement | 7.47e-05 | 33 | 202 | 4 | EFO_0010345 | |
| Disease | chronic obstructive pulmonary disease | HIVEP2 SPEG TPRN PPP1R12B DGKB ASAP2 RASGRP3 MICAL3 DMBT1 RUNX3 TENM4 EPOP VGLL4 L3MBTL3 TNS1 | 8.65e-05 | 688 | 202 | 15 | EFO_0000341 |
| Disease | C-reactive protein measurement | DOCK4 PCYT1A HGFAC NCOA6 TOB2 UBE4B BCL3 VIT DNAJC6 STRN MICAL3 SGIP1 ARHGAP10 PRR30 CREB3L1 SETD5 CCDC34 TLE4 RERE L3MBTL3 CUX1 | 8.88e-05 | 1206 | 202 | 21 | EFO_0004458 |
| Disease | Burkitt Lymphoma | 1.06e-04 | 36 | 202 | 4 | C0006413 | |
| Disease | Colorectal Carcinoma | SALL3 CSMD3 GJD4 KMT2C SULT2B1 EVL SRSF6 SYNE1 RTN4 APC LIG1 EXO1 CTNND2 PIK3R5 CUX1 | 1.08e-04 | 702 | 202 | 15 | C0009402 |
| Disease | alcohol consumption measurement | HGFAC TOB2 RAPH1 CSMD3 KLHL29 NFATC2 RABGAP1L FBXO42 COBL MICAL3 TET3 SGIP1 RTN4 DENND1A CREB3L1 MICALL1 AUTS2 RERE CTNND2 AGRN CUX1 | 1.33e-04 | 1242 | 202 | 21 | EFO_0007878 |
| Disease | Familial vesicoureteral reflux | 1.39e-04 | 3 | 202 | 2 | cv:C4706552 | |
| Disease | Familial vesicoureteral reflux | 1.39e-04 | 3 | 202 | 2 | C4706552 | |
| Disease | Vesicoureteral reflux | 1.39e-04 | 3 | 202 | 2 | cv:C0042580 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 1.66e-04 | 16 | 202 | 3 | DOID:0050888 (implicated_via_orthology) | |
| Disease | Benign neoplasm of stomach | 2.00e-04 | 17 | 202 | 3 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 2.00e-04 | 17 | 202 | 3 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 2.00e-04 | 17 | 202 | 3 | C0154060 | |
| Disease | asthma | TOB2 HIVEP2 NFILZ BCL3 CSMD3 NFATC2 MYRF USP36 RUNX1 RUNX3 PIKFYVE USP10 RERE CTNND2 MUC2 | 2.24e-04 | 751 | 202 | 15 | MONDO_0004979 |
| Disease | diffuse plaque measurement | PPP1R12B DAPK1 CSMD3 DNAJC6 PTPRG DMBT1 ATG9B CECR2 CBLB TENM4 LINC00173 ROBO2 RERE LINC00114 TNS1 | 2.47e-04 | 758 | 202 | 15 | EFO_0010699 |
| Disease | amino acid measurement | DGKB KLHL29 PTPRG RABGAP1L COBL FLRT2 ZNF704 SYNE1 BUD13 LRRK1 LIG1 TENM4 NISCH MUC2 | 2.60e-04 | 678 | 202 | 14 | EFO_0005134 |
| Disease | Vesico-Ureteral Reflux | 2.77e-04 | 4 | 202 | 2 | C0042580 | |
| Disease | syndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology) | 2.77e-04 | 4 | 202 | 2 | DOID:0060809 (implicated_via_orthology) | |
| Disease | Precursor B-cell lymphoblastic leukemia | 3.84e-04 | 21 | 202 | 3 | C1292769 | |
| Disease | Stomach Carcinoma | 3.84e-04 | 21 | 202 | 3 | C0699791 | |
| Disease | vesicoureteral reflux (is_implicated_in) | 4.60e-04 | 5 | 202 | 2 | DOID:9620 (is_implicated_in) | |
| Disease | Autistic Disorder | 4.61e-04 | 261 | 202 | 8 | C0004352 | |
| Disease | testosterone measurement | DOCK4 PCYT1A HGFAC NCOA6 TPRN DGKB CSMD3 EBF2 PTPRG CGB2 SKOR2 DNMBP ZNF704 ARHGAP10 CECR2 ZFHX4 TRAPPC12 NISCH AUTS2 L3MBTL3 | 5.07e-04 | 1275 | 202 | 20 | EFO_0004908 |
| Disease | basophil count | ZYX KLHL29 BIN2 FOXO1 KIAA0930 TRIOBP RUNX1 RUNX3 RERE L3MBTL3 TNXB | 5.34e-04 | 483 | 202 | 11 | EFO_0005090 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 6.47e-04 | 152 | 202 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | eosinophil percentage of leukocytes | GRIPAP1 HIVEP2 BCL3 NFATC2 TET3 FOXO1 BUD13 RUNX1 RUNX3 EXO1 RERE MUC2 PIK3R5 CUX1 | 6.69e-04 | 746 | 202 | 14 | EFO_0007991 |
| Disease | laryngeal carcinoma (is_marker_for) | 6.87e-04 | 6 | 202 | 2 | DOID:2600 (is_marker_for) | |
| Disease | response to norepinephrine-dopamine reuptake inhibitor | 7.32e-04 | 26 | 202 | 3 | EFO_0007870 | |
| Disease | heart rate | 9.54e-04 | 225 | 202 | 7 | EFO_0004326 | |
| Disease | Rectal Neoplasms | 9.57e-04 | 7 | 202 | 2 | C0034885 | |
| Disease | Rectal Carcinoma | 9.57e-04 | 7 | 202 | 2 | C0007113 | |
| Disease | inter-alpha-trypsin inhibitor heavy chain h4 measurement | 9.57e-04 | 7 | 202 | 2 | EFO_0020481 | |
| Disease | RS-10-hydroxywarfarin to RS-warfarin ratio measurement | 9.79e-04 | 110 | 202 | 5 | EFO_0803335 | |
| Disease | daytime rest measurement | 1.02e-03 | 295 | 202 | 8 | EFO_0007828 | |
| Disease | Malignant neoplasm of breast | NCOA6 RAPH1 PPP1R12B PGR EVL SYNE1 MICALL1 TRAPPC12 NISCH SIPA1L1 EXO1 ZFYVE26 ELK3 L3MBTL3 TNS1 CUX1 ZNF646 | 1.22e-03 | 1074 | 202 | 17 | C0006142 |
| Disease | eicosapentaenoic acid measurement | 1.23e-03 | 31 | 202 | 3 | EFO_0007760 | |
| Disease | interleukin-8 measurement | 1.23e-03 | 31 | 202 | 3 | EFO_0004811 | |
| Disease | Cornelia De Lange Syndrome | 1.27e-03 | 8 | 202 | 2 | C0270972 | |
| Disease | Eczema | 1.40e-03 | 310 | 202 | 8 | HP_0000964 | |
| Disease | feeling tense measurement | 1.48e-03 | 33 | 202 | 3 | EFO_0009596 | |
| Disease | bone density | 1.50e-03 | 388 | 202 | 9 | EFO_0003923 | |
| Disease | asthma, Eczema, allergic rhinitis | 1.50e-03 | 121 | 202 | 5 | EFO_0005854, HP_0000964, MONDO_0004979 | |
| Disease | Liver Diseases, Parasitic | 1.63e-03 | 9 | 202 | 2 | C0023897 | |
| Disease | sexual dimorphism measurement | NCOA6 HIVEP2 BCL3 TAOK2 KLHL29 SSC5D PTPRG MYRF CSTPP1 USP36 CDC42BPA HDAC5 RTN4 APC BUD13 TEAD3 L3MBTL3 | 1.66e-03 | 1106 | 202 | 17 | EFO_0021796 |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 1.69e-03 | 74 | 202 | 4 | DOID:3748 (is_marker_for) | |
| Disease | cortical thickness | NFILZ DAB1 VIT KLHL29 STRN FBXO42 KMT2A MICAL3 TRIOBP DENND1A MICALL1 SETD5 AUTS2 ROBO2 RERE TNS1 SH3RF3 | 1.77e-03 | 1113 | 202 | 17 | EFO_0004840 |
| Disease | Developmental delay (disorder) | 2.07e-03 | 37 | 202 | 3 | C0424605 | |
| Disease | allergic disease | 2.09e-03 | 258 | 202 | 7 | MONDO_0005271 | |
| Disease | Glioblastoma | 2.15e-03 | 79 | 202 | 4 | C0017636 | |
| Disease | age of onset of asthma | 2.15e-03 | 79 | 202 | 4 | OBA_2001001 | |
| Disease | PR interval | 2.30e-03 | 495 | 202 | 10 | EFO_0004462 | |
| Disease | unipolar depression, mood disorder | 2.34e-03 | 134 | 202 | 5 | EFO_0003761, EFO_0004247 | |
| Disease | Gastric cancer | 2.46e-03 | 11 | 202 | 2 | cv:C0024623 | |
| Disease | Neoplasm of stomach | 2.46e-03 | 11 | 202 | 2 | cv:C0038356 | |
| Disease | Ankylosing spondylitis | 2.46e-03 | 11 | 202 | 2 | C0038013 | |
| Disease | meningitis | 2.46e-03 | 11 | 202 | 2 | MONDO_0021108 | |
| Disease | triacylglycerol 56:2 measurement | 2.46e-03 | 11 | 202 | 2 | EFO_0010429 | |
| Disease | invasive ductal carcinoma (is_implicated_in) | 2.46e-03 | 11 | 202 | 2 | DOID:3008 (is_implicated_in) | |
| Disease | GASTRIC CANCER | 2.46e-03 | 11 | 202 | 2 | 613659 | |
| Disease | uterine fibroid | 2.56e-03 | 199 | 202 | 6 | EFO_0000731 | |
| Disease | lymphocyte count | RAPH1 UBE4B MS4A12 ZNF295-AS1 KLHL29 BORCS5 NFATC2 MICAL3 DMBT1 SLC4A7 RTN4 JPH2 RUNX3 TENM4 TLE4 AUTS2 ROBO2 RERE LY9 L3MBTL3 | 2.65e-03 | 1464 | 202 | 20 | EFO_0004587 |
| Disease | Giant Cell Glioblastoma | 2.68e-03 | 84 | 202 | 4 | C0334588 | |
| Disease | Carcinoma, Transitional Cell | 2.78e-03 | 41 | 202 | 3 | C0007138 | |
| Disease | endometrial carcinoma (is_implicated_in) | 2.94e-03 | 12 | 202 | 2 | DOID:2871 (is_implicated_in) | |
| Disease | outer ear morphology trait | 2.94e-03 | 12 | 202 | 2 | EFO_0007664 | |
| Disease | Intestinal Neoplasms | 2.94e-03 | 12 | 202 | 2 | C0021841 | |
| Disease | Intestinal Cancer | 2.94e-03 | 12 | 202 | 2 | C0346627 | |
| Disease | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2.94e-03 | 12 | 202 | 2 | C0023485 | |
| Disease | stomach cancer (is_marker_for) | 3.01e-03 | 142 | 202 | 5 | DOID:10534 (is_marker_for) | |
| Disease | respiratory system disease | 3.29e-03 | 145 | 202 | 5 | EFO_0000684 | |
| Disease | pulse pressure measurement | HGFAC RAPH1 POGZ EBF2 KLHL29 FNDC1 ASAP2 NFATC2 CCDC157 USP36 SLC4A7 SGIP1 WIPF1 TRIOBP JPH2 RNF126 TENM4 ZFHX4 CTNND2 | 3.40e-03 | 1392 | 202 | 19 | EFO_0005763 |
| Disease | level of Phosphatidylinositol (18:1_18:1) in blood serum | 3.46e-03 | 13 | 202 | 2 | OBA_2045159 | |
| Disease | Uterine leiomyoma | 3.58e-03 | 91 | 202 | 4 | HP_0000131 | |
| Disease | resting heart rate | 3.69e-03 | 149 | 202 | 5 | EFO_0004351 | |
| Disease | fasting blood glucose measurement | 3.76e-03 | 287 | 202 | 7 | EFO_0004465 | |
| Disease | Neurodevelopmental Disorders | 3.87e-03 | 93 | 202 | 4 | C1535926 | |
| Disease | QT interval | PTPRG MYRF SGIP1 CDC42BPA HDAC5 ARHGAP10 BTBD10 HES3 SIPA1L1 CUX1 | 3.93e-03 | 534 | 202 | 10 | EFO_0004682 |
| Disease | asthma, body mass index | 4.02e-03 | 14 | 202 | 2 | EFO_0004340, MONDO_0004979 | |
| Disease | X-21470 measurement | 4.02e-03 | 14 | 202 | 2 | EFO_0800817 | |
| Disease | lysophosphatidylcholine 22:5 measurement | 4.02e-03 | 14 | 202 | 2 | EFO_0021462 | |
| Disease | systolic blood pressure change measurement | 4.11e-03 | 47 | 202 | 3 | EFO_0006944 | |
| Disease | calcium measurement | HGFAC NCOA6 RNF217 ASAP2 DMBT1 CCDC157 TRIM46 BTBD10 FCHO2 TLE4 L3MBTL3 | 4.19e-03 | 628 | 202 | 11 | EFO_0004838 |
| Disease | prostate cancer (is_marker_for) | 4.49e-03 | 156 | 202 | 5 | DOID:10283 (is_marker_for) | |
| Disease | alcohol use disorder measurement, alcohol consumption measurement | 4.50e-03 | 97 | 202 | 4 | EFO_0007878, EFO_0009458 | |
| Disease | Stomach Neoplasms | 4.53e-03 | 297 | 202 | 7 | C0038356 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TEPSPTPSSPNRTAE | 621 | P23470 | |
| ARSPSSSLQPRHPAP | 41 | Q7Z4H4 | |
| LPPSNPCRLTPTLSS | 61 | Q6XXX2 | |
| PSPARSSPVNRPSSA | 716 | Q96L91 | |
| PRLSSTNSSRFPPSP | 721 | P53355 | |
| TNSSRFPPSPLASKP | 726 | P53355 | |
| SSDSDLSPPRRSQPP | 401 | Q9BRD0 | |
| SSSRPSSPRPQKASP | 106 | Q9BSF8 | |
| ASRQPVPRLPPSSSV | 456 | Q96LX7 | |
| SDGSQSPRSLPPSSP | 216 | Q96BA8 | |
| RSSPSGPSNPSNPSV | 206 | Q8WY22 | |
| PRTSSTQCSSVPEPR | 1871 | Q7Z407 | |
| NPSRPAPTNTSLTGP | 766 | A6NCI8 | |
| SRSETPQNSPLPSSP | 901 | P39880 | |
| LAPPPRERPASSSSS | 46 | Q8NFJ8 | |
| VPQSAPPVPTASSRF | 136 | P41162 | |
| VTSNTSPPPAAPLAR | 491 | Q0JRZ9 | |
| TAHSQTTPPPSSRPR | 1011 | O00468 | |
| PRNPSQLPALSSSPA | 406 | Q9HAK2 | |
| PNPSRSPCLPDSTSL | 86 | Q86UB2 | |
| PSRCPSDPDSTSQPR | 1431 | Q6XZF7 | |
| PQALTRSNSLSTPRP | 1106 | Q9Y4F5 | |
| RATASPRPSSGNIPS | 421 | Q9UBW5 | |
| PRPSSGNIPSSPTAS | 426 | Q9UBW5 | |
| APTAQVPPSLPRNST | 326 | Q9NPI6 | |
| CTSPPRQPCTSPSRQ | 686 | Q569K6 | |
| PTPPLQTDCTRQSSP | 1001 | Q9BXF3 | |
| TPSISPVRVSPNNRS | 1056 | Q9UQB3 | |
| TQPPTLSIPNPSRSY | 381 | O43155 | |
| SAPPATSNPDPAVSR | 696 | Q14624 | |
| PPPTPQRNSSIKSSS | 971 | Q70E73 | |
| TSPRSPQESASPTLN | 166 | A0A5F9ZHS7 | |
| ASPAPAPSRSPSAQC | 376 | P78411 | |
| VPTAQEAPTSPPSSR | 66 | Q96JM7 | |
| TCLSASPPNAPPRQS | 586 | A1A4S6 | |
| RAPLSPSLNSRPSPI | 361 | Q6P3S6 | |
| GASPQRSRSPSPQPS | 266 | Q13469 | |
| RSRSPSPQPSSHVAP | 271 | Q13469 | |
| PLQCSPTSSQRVLPS | 61 | Q9BZE7 | |
| VPTSASAPPRVNTPS | 1506 | Q14667 | |
| PSSPATAPLQAPTLR | 596 | Q9BR39 | |
| TVPSPTQSPIRFQPA | 1271 | Q7RTP6 | |
| PPSPQVFSPGSSNSR | 1876 | Q8NEZ4 | |
| FPQASSPSSPSRRET | 156 | Q96PY0 | |
| TAPASSPADSPRPQA | 351 | O75112 | |
| CPTSAPPSPTRTRGN | 31 | Q9Y4Z2 | |
| SSPPRQAARSPSSLP | 1846 | Q38SD2 | |
| CLSRAPQPTSPPASR | 351 | Q86UW9 | |
| ASPPRPLLSNASATP | 181 | Q9NQW6 | |
| SRQRSSSDPPAVHPP | 816 | O43150 | |
| SASSPPPPRALQAES | 746 | Q99665 | |
| TSFSTPPTPERNNRP | 286 | Q6ICG6 | |
| SPVTSPGSSPLAQRR | 476 | Q13191 | |
| SRLAAPPSCSSLQPP | 336 | Q96KN9 | |
| PTSRPPENSASAQSP | 411 | A6NNH2 | |
| PKQSPSSSPTRERSP | 316 | P49585 | |
| SASPQPSSVAPRRPQ | 266 | P52945 | |
| PKQSPVSSPTRSRSP | 316 | Q9Y5K3 | |
| TSNPPPESSTPQTSR | 4211 | Q02817 | |
| PSTSPSPGTRAASQP | 301 | Q9UI08 | |
| SASVPPPQPASSRCA | 151 | Q5TGS1 | |
| SNNSSISRPAAPPEP | 51 | O14511 | |
| SSRSSTPAKTQPAPP | 406 | Q8WXX7 | |
| RSPVPSPGSSSPQLQ | 611 | Q8N3F8 | |
| PAQQTDRSSPVRPSS | 1376 | Q9UGL1 | |
| TSPPDSSQRPSARPA | 61 | O15522 | |
| PPRAVPSSSSPQAQA | 86 | Q04756 | |
| SVPSPSPRPQALDAT | 296 | O95402 | |
| APPRRPPQSASSLSA | 271 | Q02080 | |
| PPQSASSLSASLRPP | 276 | Q02080 | |
| DPSNTEISTPRPSSP | 106 | Q5R372 | |
| FSSPASSRSQTPERP | 21 | A6NF01 | |
| RPVSSSSISTPLPPN | 1581 | Q14686 | |
| SRATPVQLPSPPCTS | 1736 | Q14686 | |
| PPRSSPCASSTPVAV | 341 | P06401 | |
| PFSSPASSRSQTPER | 436 | Q96HA1 | |
| PRFQASSSSKAPPPS | 131 | Q6NT52 | |
| SPQLPSRTQSVRSPT | 76 | Q9Y2I7 | |
| TPCPSEPNTPTARTF | 166 | P14653 | |
| PLPRPEFSQSNSATS | 26 | Q12778 | |
| PPRPTQTASPARHTT | 1791 | Q8N1I0 | |
| PTPAPRQSSPSKSSA | 516 | O75553 | |
| TASPEASCLPSRTPP | 286 | Q9H6J7 | |
| PSPPLPLSCSNSTRS | 51 | Q96HJ3 | |
| PRESTTSFASAPPRP | 146 | A6NHQ4 | |
| FSPQRVSPTTSPRPA | 291 | Q99501 | |
| PRPALSPSRQSPSSV | 666 | Q4ZHG4 | |
| PRLQPSSSPQSTVPS | 841 | Q4ZHG4 | |
| PSSACTRPPSAPVNL | 321 | P29322 | |
| PPPSQALSAPRTASR | 1211 | O75128 | |
| SSDPFLQPTRSPSPT | 606 | O75061 | |
| SRPNDLNSSVTPSPA | 11 | Q969J3 | |
| VPSSQRLPEPRASSS | 511 | Q5T0F9 | |
| ITPPRTTSPANTCSP | 116 | Q9Y6T7 | |
| SPLSTAQAPLPNPRT | 211 | P40198 | |
| ASILSRPCSSPSQPP | 856 | Q674R7 | |
| STPALSRRTPSPSQG | 956 | Q9P203 | |
| SRSPSLSPNSPLPSE | 241 | P41970 | |
| PSPSIQRNPTASAAP | 851 | Q6VMQ6 | |
| PLRPARQQPTPTSDS | 521 | Q9HBG7 | |
| SRPTSQVPAQCRPPS | 56 | Q8IX19 | |
| STLPSRPATPNVATP | 796 | Q8TEH3 | |
| TRSPTVPSQNPSRLA | 2936 | Q03164 | |
| RKASPSPSSARTQPP | 206 | Q9NQR7 | |
| SPSSARTQPPPAGSR | 211 | Q9NQR7 | |
| RPTSPRNISPISNPV | 71 | Q1W209 | |
| RPLSRTQSSPLPQSP | 491 | Q9UQL6 | |
| SPETAPAARTPQSPA | 486 | Q9Y613 | |
| PASTAALRTTPSPPS | 206 | Q8N9H9 | |
| VVRPQASPPPSCTSA | 566 | Q9H4W6 | |
| ARSLSSSPQAQPPRP | 686 | Q4V328 | |
| SASPSSSPSQSPPRD | 396 | P20749 | |
| SPPRPATSPENNASL | 91 | P18858 | |
| VICSAPQSRPTPSPD | 331 | Q9UGM3 | |
| SLSPCPPQRRFSLSP | 221 | Q9NYF3 | |
| ADSPSATPASRSPQR | 541 | Q9BXA9 | |
| ATPASRSPQRPSPAS | 546 | Q9BXA9 | |
| RSPQRPSPASSECAS | 551 | Q9BXA9 | |
| QSPARAPSTSPPSSR | 221 | Q8NCU7 | |
| PPLQPRDSASPSTSS | 86 | Q13620 | |
| ASSRAPSPPPTASNS | 371 | Q8N108 | |
| ELPRRVNSASSSNPP | 376 | Q9BY77 | |
| PNITVSSRSPPAPRF | 1611 | Q6ZRI0 | |
| PVTPASSSAPPRCNN | 246 | Q9NXJ0 | |
| PGPLPSTTQPSQASR | 571 | Q75VX8 | |
| RSPPRILPPCTNAST | 396 | Q01196 | |
| DPSTSRRFTPPSPAF | 6 | Q13761 | |
| QSPLVSSSDSPPRPQ | 6 | Q9NQC3 | |
| SQNPSPGSSSPRPSV | 301 | Q86VV8 | |
| ASFPRSPGQPSSLRS | 1646 | Q5T011 | |
| QPSVGSPSRPSSSRL | 371 | O43815 | |
| EPTSPASTPSTRSPR | 76 | Q7Z4K8 | |
| PPRPSQASPDTATST | 1091 | Q68CR1 | |
| PQNSPPSSPSISRLT | 306 | Q9Y6M7 | |
| NTSLEREPRPNSSPS | 336 | O00204 | |
| PSPQPSPRDQQSSSS | 2701 | Q9UQ35 | |
| SEISSPPACRSPSPV | 5871 | Q8NF91 | |
| PRSTPPARAASPSSS | 131 | A6NKL6 | |
| EPRNSKSQPTSPTTP | 381 | Q8IV61 | |
| QPRTVPVSSNDTPPS | 696 | Q7Z3K3 | |
| RSAGTSSRNPASRPP | 81 | Q9H6K5 | |
| TKQPRTPRPPSTSQA | 336 | O94933 | |
| ALSQPSSVPTRPRTP | 21 | Q5T036 | |
| SAPSTAPTDQSRPPL | 51 | Q9BV68 | |
| NPTSNSDRPVTRPLA | 391 | Q5FBB7 | |
| PQSPFPSTPTSRRAL | 1566 | O43166 | |
| PRRSCPSSAASPTLQ | 1336 | Q9C0A6 | |
| PPAAPAPTSTTSSAR | 441 | Q9UL54 | |
| SSSSLPCPAPNSRPA | 66 | O15457 | |
| TASTPVNTPSRPPSS | 466 | Q9P2R6 | |
| NPPSTRSSFPSPRLS | 196 | Q8TC41 | |
| RSQSRSNSPLPVPPS | 296 | Q13247 | |
| VPPTAPTDSNNSTPR | 411 | A1L4H1 | |
| SSPPLPLPSCSRQVD | 231 | Q9NUC0 | |
| PRAASAPPTDRSPQS | 851 | E7EW31 | |
| NSSNLSSPPSPASPR | 1701 | Q5VT25 | |
| TPSPSPSTALQQFRR | 621 | Q9UQ84 | |
| LRPTQSDGPRTSSPS | 911 | Q9H2D6 | |
| RPQTSSPSRPAQHDP | 946 | Q9H2D6 | |
| IAELPSSTPARPSPQ | 586 | Q8WZ75 | |
| SSTPARPSPQVPAVR | 591 | Q8WZ75 | |
| DSTPSRPAQQPLSRP | 2306 | P25054 | |
| SPSSRPASPTRSQAQ | 2466 | P25054 | |
| PLPSPSRRSSQSAPT | 196 | Q8IXR9 | |
| SSPESASRRGQPASP | 261 | Q14135 | |
| RSPSRSPSHSPNRSP | 346 | Q15735 | |
| RPSPVPSTPASAQAS | 371 | Q5JTD0 | |
| PATQTPRPQARASSR | 91 | Q6ZV60 | |
| ARRAASPPSSPPSLS | 3486 | Q86UP3 | |
| PAPPTSSTAQPRREC | 1226 | Q7Z2Z1 | |
| RAVSPAAAQPPSPSS | 546 | Q15772 | |
| RSQTPSPPTDSPRHA | 576 | Q8WYR1 | |
| PTNLNPSTCPSRPSV | 826 | Q9UBZ9 | |
| ASARTPPQVVQPSPS | 191 | Q8WVT3 | |
| LTSQQPSTSRQDPPP | 566 | Q96MW7 | |
| SKSNTPTPRTDAPTP | 321 | Q04727 | |
| EASQTPRPSASPATP | 401 | Q8TDD2 | |
| SSPARPATPLVPCRS | 441 | Q9BQI5 | |
| SPLRTQNSPSRLPAT | 626 | Q8TEJ3 | |
| GPTTPPQRRRSSAQS | 176 | Q2MJR0 | |
| SSPQRRQSPSPSTRP | 706 | Q8IYB3 | |
| PPSPLPQAVFSTSSR | 146 | Q99594 | |
| SSSRQRPSSTGPPLP | 366 | O95155 | |
| PSHPPSTRITRSQPN | 171 | Q9BQ15 | |
| FSSRSNVTLPAPRPP | 26 | P22105 | |
| QSPEATSPRSPGVRS | 906 | Q9HBL0 | |
| RPSSSPPTVAPASAS | 486 | Q9Y2I1 | |
| RSPSPCLSSQPSSPS | 6 | Q8IYM1 | |
| APSTSSTERPSPNGP | 381 | Q8NCP5 | |
| TNSARAPPLPIPASS | 191 | O15015 | |
| PRPSPSAASTTSIPR | 201 | Q6UXI7 | |
| FARPNPVVSPSPLTS | 1016 | Q6N022 | |
| ERSSPRTLPPVNSNS | 346 | Q9H1K6 | |
| RQSPLSSSSPFSNRP | 236 | O43516 | |
| QRPRPTSPFSTDSNT | 1261 | Q9HCK4 | |
| SPPTASLTRTPPRAS | 321 | A8MUU9 | |
| SSSPAPAPSPVLQRE | 496 | O43151 | |
| SPSSAFQPDTLSQPR | 16 | Q2VWA4 | |
| SLASPPTFPIPDSSR | 261 | Q6ZNC4 | |
| TPASPPASATPSQRQ | 271 | Q4KMQ1 | |
| PLSSSSPQPSQPSRE | 541 | Q13470 | |
| DPRNSSPRLNPLSSA | 221 | Q9UIW0 | |
| SPRLNPLSSASASPP | 226 | Q9UIW0 | |
| SLANTQPRGPPASSP | 246 | Q15942 | |
| PPSVTPRTCNSPQNS | 201 | Q14694 | |
| RPQNSPQTTPRPAAS | 31 | Q96RP3 | |
| PQTTPRPAASESPSA | 36 | Q96RP3 | |
| AQPHRRLPAPPSSSS | 11 | Q8N0V1 | |
| SSSIGSPQASSPPRP | 36 | Q9P0T4 | |
| PSQPPFSSTQSRRPS | 46 | Q53SZ7 | |
| FSSTQSRRPSSPPPA | 51 | Q53SZ7 | |
| APVSAPRPASSPARS | 51 | Q6ZS46 | |
| TSPQPPRFSSLPVNV | 1936 | P31629 | |
| QSSGPPSTPSSPRLL | 2291 | P31629 | |
| QQRRSPASPSCPSPV | 381 | A7MCY6 | |
| RAPSRSASPSPPESL | 186 | Q04725 | |
| PSLRERSFPPTQPSQ | 1781 | Q68DK2 | |
| SPSPTFIPRSAQPIT | 161 | Q14106 | |
| SVNRVPPSSPSSQEP | 376 | Q9H347 | |
| QPADPSTPERQSSPS | 441 | O15231 | |
| SSPSPSTSNQLPRPV | 551 | Q96ND8 | |
| SSQASDNPFSPPRTL | 1136 | Q6PFW1 | |
| VSPAPQSSSRLQPPF | 741 | Q9P275 | |
| VEPLPPRPSSDQSSS | 1516 | O95071 | |
| STPPSSPELSREPSQ | 146 | Q99612 | |
| SRLPTPATAPAPCTT | 61 | Q96CT2 | |
| VPRLLSSPRPNPTSS | 1216 | P41229 | |
| QPDKPTTPASPSTSR | 726 | O60237 | |
| SPSPSPSTNRSGPSQ | 911 | Q9Y2G1 |